Gentral Rate Contract: Supply of

ESIC
GENTRAL RATE CONTRACT NO. - 143(C)

FOR SUPPLY OF DRUGS & DRESSINGS
(VALID FROM 14th October,2021to 31"t October, 20231
DRUGS FOR RESPIRATORY SYSTEM

DRUGS FOR CARDIO-VASCULAR SYSTEM
DRUGS ACTING ON CENTRAL NERVOUS SYSTEM
STR]CTLY FOR OFFICIAL USE
2A2L-2023
EMPLOYEES' STATE INSURANCE CORPORATION

ROOM NO.312 & 314, HQRS. OFFICE, PANCHDEEP BHAWAN
C.I.G. ROAD, NEW DELHI- 110 OO2
ESIC
CENTRAL RATE CONTRACT NO. - 143(G)
FOR SUPPLY OF DRUGS & DRESSINGS
20231
(VALID FROM 14th October,2021to 31"t October'
D R U G S F o R R E S P I RAT o RY S Y S TE
M
DRUGS F SYSTEM
DRUGS AC TI US SYSTEM
STRICTLY FOR OFFICIAL USE
2*2:"-2*23
PUBLISHED BY
DIREGTOR GENERAL
EMPLOYEES' STATE INSURANGE CORPORATION
-ioon No.312 &314,HQRS. oFFlcE, PANcHDEEP BHAwAN
C.I.G. ROAD, NEW DELHI- 110 OO2
Sno. Contents Page
No.
1. Fonararding letter along with terms & t-x

conditions for operation of Rate Gontract
No. 142 (C).
2. List of Approved Pharmaceutical firms. 1-3
?,FtA R*- - a4/rrl

3 A ddress with Terms & Conditions of the 1-17
Eligible firms
4. lndex 1-8
.e=
5. Rate Schedule 1-50
=i,.) ) 1)O)A
STRICTLY F OR OFFICIAL U SE ONLY
offirrqffcrfurc ITqTdq/HEADQUARTERS'
qna
('Ic Fi {tsqE dililq,
EMPLOYEES' STATE INSURANCE
wiFrg W
^4^
,#r*t
riq{q rr+q, S"qdd rn f, +{ ffi
- r ro ooz
Panchdeep Bhasan,C.I.G' Matg,New Delhl-110002
CORPORATION Htdd www.esic.nic.in, 80 1 1-23234334,8 dmc-rdaresic nic.in
(Ministry of Labour & Employment, Govt. of
lndia)
No.U-ZslLzlt42C-1 RC 202t
rl
From
The Director General,
E.S.I. Corporation,
Panchdeep Bhawan,
C.I.G Road,
To
Director (Medica
Dean, Colleges & Hospitals,
Medical
Director, ESI
Sub r PURCHASE OF UNDER THE E.S.I.

DRUGS AND DRESSINGS
CORPORATION CENTRALISED RATE CONTRACT NO. 143C EFFECTIVE
FROM 14.10.2021 TO 31.10.2023 .
Sir / Madam,
Please flnd for

supply of drugs and
Validity of this i.e. w.e.f,

14.1O.2O21 to 31'10'20
Further, the following terms operation of the Rate

Contract:-
1. ImmediatelY on receipt of this communication, the Chief Direct Demanding Officers

(Director/Addl. Director/J ECI ( I Officer/Diredor
( Medical) Delhi & Noida shal and the officers who
have been designated as ration of this
Contract holders
Rate Contract on his beha toa the Rate ntract ers.
would entetain the suPPlY o rders & related correspondences from the officers working as
DDOs only after the receiPt of such communication from the Chief DDOS.
I
2 supply orders will be placed by Heads of ESI Scheme of various states/ Deans/ lt4edical
Superintendents, ESIC [vlodel Hospitals, who for the purpose of this Rate Contract, shall be
designated as chief Direct Demanding officer and will exercise the powers of Director
General, ESI Corporation in all matters connected with the execution of supplies and / or
wherever specifically provided in the terms & conditions of the Rate Contract' The Chief
Dlrect Demanding Officer can also designate any of his subordinate officer as Direct
Demanding Officer (DDO) to operate this Rate Contract.
J All the supply orders shall be signed only by the officers who have been duly authorised
and included in the:.list of'DDos.-DDOs-.will send rynn4{.9py of the Purchase
order through email.followed, by speed post directly tothe firm'',
':: ', . -..:1.
4 The Chief DDOs may bring to the notice of the undersigned the discrepancies (especially in
rate, packing, composition of the drug) if any observed by them'
5. The Chief DDOs shall monitor of the Ra holding flrms in regard

to their execution of suPPlY ated quaterly non-
supply report along with th il sasun
R.C. Item No. & Name of S.O..:No; Qty. not Risk Payment Remarks
No. Name of firm with supplied Purchase/ if
Drug Date penalty pending
levied
1 2 3. 5 6. 7. 8.
l
nder this
6. The applicabilitY
rates.
Act or
7. It will be ensured beford'placing ordqr. by the t necessary

funds are available and PaYment be arranged ithin 4-6 week
time of the execution of the orders bry.the Rate Contract Holder and there should
not be
unnecessary delay in the payment of their bil!5: '
in which
B supply orders will be placed from time to time during the currenry of the contract
tt-ili.a qrirtities required on each occasion together with the date. of delivery shall be
specifiedbytheDirectDernandin$.officers..,..i.....l'l
No guarantee can be given..as io the.,minimim quantiry frntir iritt be.di'awn against

thls
9
quantity as may be ordered by the Dlrect
.ont"ru.t but the pharmaceutical firm will supply
Demanding Officers during the currenry of the contract
l0.supplyordersagainstthecontractwillbeacceptedaslongasthesereachthe
pharmaceutical firm on or before last date of the currency of the contract' Supply
orders
received during the closing days should be complied within due course,
in accordance wlth
supplies are
the contract iieven thoug'h in some cases owing to contract having expired,
to be complied with even;fter the expiry of the last date of the contract'
II
11. Notwithstanding any omission or shortcoming in the supply order it is incumbent upon the
Pharmaceutical firm to supply the item as per the specifications of the relevant rate
contract.
SUPPLIES
12. The purchaser will not pay separately for transit insurance and the contractor will be
responsible for delivery of items covered by the supply order in good condition at the
specified destination and for this purpose freight, insurance, Octroi etc, if any, will have to
be borne by the supplier. {he consignee'will, as-soon as po:qible, but.iiot later:than 30
days of the date oi arrival of stores at destination, notify the contractor of any loss or
damage to the storei,,that ma, lilve occurred ilu.ring thertr.anSiL ''.'..,.,' '... ,''
13. During transit pharmaceutical firm should maintain the recommended

temperature of the drug (wherever indicated), otherwise if on checking it is
found that temperature has not be€n mairitaind, supply,?gainst the said order
is liable to be rejected and cancelled. It will ber"counted as t non-supply.
14. The prices approved are FIO,R. Destination per unit and are exclusive of GST except
where indicated but inclusive of.all charges for packing and forwarding.
15. In all contracts for items/ drugs, which are branded with 'ESI SUPPLY' mark including
rejected items/ drugs, it would be a condition that such items/ drugs will not be sold to the
public/open market.
16. Marking:
Each packing shall be printed with nomenclature of the shall be

labelled in accordance with the Drugs Act,
1940 and the rriles iiiade theie under. drug must
comply with the procedure provided under the Legal 2009 and
rules made there under.
17. Packing:
a) rt s[ould be ensured that all labelg-,of cartons, ampoules,'vialg bottles, jars,
tubes, tins, containers etc.i. have "For ESI rypply, Not to be sold"
imprinted/rubber stamping with indelible irlk clearly. Any consignment
wiihout such stamping will not be considered valid and will be rejected.
b) Loose supplies/damaged packing/tempered or damaged labeled supplies shall not be

accepted under any cireumstancest''a
c) Supplies to be made in, propeir boxes' . -i. - l

d) Liquid orals to besupplied only in glass/ plastic bottles conforming to Drugs &
Cosmetics Act and rules made there under.
e)
- Large volume parenterals to be quoted and supplied only in plastic bottles / polypacks
conforming to Drugs & Cosmetics Act and rules made there under'
III
fl It should be ensured that only firct use packaging materia! of uniform size
for making supplies on the basis of ESI
including Bottles and vials should be used
Rate Contract.
g) All primary packing containers should be strictly conforming to the specifications

described/ mentioned in the relevant pharmacopoeia.
h) Packing should be able to prevent damage or deterioration during transit.
i) All containers i ei, bottles,.tins; carto$g tubes etc', are required tor-be secur€d with
.
pilfer-proof sealito ensurergenuinenels of the products packed and the corredness of

the contents. MRP should not be written on any labels othdriiVise,.itwill disqualified.
18. Life Period :

.) For Drugs having shelf life of Two years or less: As on the date of delivery,
Drugs should noi be older than one fourth (1/a) of its shelf life from the date of
manufacture.
b) For Drugs having shelf life more than Two years: As on the date of delivery,
Drugs s[ould noi be older than one sixth (U6) of its shelf life from the date of
manufacture.
c) Imported Drugs: As on the date of delivery, Drugs should have a minimum

500/o of valid shelf life from the date of manufacture.
rm!
sEores a
19.
mentioned against each
sro ns of Drug and Cosmetics
Act.
20. The Stores accePted sh ould comply With the provisions of-the Drugs ?nd Cosmetics Act,
1940 and the Rules m ade thereun tiiir a s amended llpto latb and Drug Price Control
Order.
21. It should be ensured that IsI code No, is indicated on the packing and at the time of
supplies, it must be ensured that the items supplied has ISI Mark as well as code
No.,
as ls the statutory requirement of the Bureau of Indian standards'
IV
22, Testino of Drugs - Oualitv Control
a. Approved Rate contract Holder should submit a Test Repoft that particular
bitch of medicines tested by the Governmenv Government approved
Laboratories (as per list circulated from ESIC Hqrs/ Hospitals/ state Govt. from
time to time) along with each supply.
b. The Director General, ESI Corporation shall be at liberty to undeftake regular

and random testing of the drugs supplied by the pharmaceutical
regular interval.to maintain and ensure the aUllitY of'drugs.r
c. The Chief D.D.OS may get at least l0o/o of the drugs tested
Laboratory, or in anY of the Govt. Approved laboratories' Instructions issued in
this regard from Hqrs. Offlce time to time.may please be adhered to'
d. Details of the items found not of standard quality should be brought to the
notice of the undersigned along with the test reports immedia!-'ly. All such test
reports should necesaarily come through Chief D'D.Os only. A'topy of the..test
report shou!(,be sent immadiately !o the firm, the'cbncerl9! Drug controllers,
and respectiVe Central Drug. Contrrjl authorities for necesaary''actloni'
at the time of suoPlv
I If any drugs supplied against this Rate Contract are found to be not of
pharmaceutical firm
standard quility on inspection by Competent Authority, th e
will be liable to replace the entire quantity within 15 days othenarise risk
purchase will be charged from the,Pharmaceutieal firmt .1,
h If the product is found t6 be.'not'.of standdid. quality','the cost of testing will be

recovered from the suPPlier.
Ifstandard quality is not maintained in h'l'o batches in two years

duration of the rate contract, the drug of the that company will be
ur""[ri"t a and debarred from running in Esrc rate gg!tE!g!-&u!
oeriod of three vears.
23
bv ESIC for each categorv of defects, described as under:-
CATEGORY'A'DEFECT (Spurious / Adulterated Drugs)-

A.
If any item / Batch of the item declared Not of Standard qualiU (NSQ) under
Category A .
. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries to
be initiated by the DDO's wherever payment had been made alrea(y, ..
Forfeiture offefoifr'ance Securiffim the respeitive,DGESICRqIe €ontract for all
the quoted drugs.
Debarring of tire Rate'contiact holdei / Pharmaieutical- firiir from current and all
future DGESIC Rate Contract for a period of five (5) years.
. Rate Contract Holder/ Pharmaceutical firm will be llable to pay damages/
compensation (if any) to individual/ individuals arising due to consumption of item
declared NSQ and in case of any adverse reaction repoted in the Hospital during
administration of the drug.
B, CATEGORY'B' DEFECT (Grossly Substandard Drugs)
I ries
II. If
pharmaceutical firm is CateggryBwithinaYear
a Recall of the NSQ item imm ta ESIS User Units. Recoveries
to be initiated by the DDO's wherever payment had been made already'
. Fofeiture of Performance security from the respective DGESIC Rate Contract
for all the quoted drugs'
o Rate Contract Holdef Pharmaceutital firm will 6e {ebarred fidr further supply of
the said NSQ item in the currency of the Rate contract'
. Debarring of Rate contract Holder/ Pharmaceutical firm immediately from
current and all future DGESIC Rate Contracts for a period of three years'
. Rate Contract Holder/ Pharmaceutical firm will be liable to pay damages/
compensation(ifany)toindividual/individualsarisingduetoconsumptionof
item declared NSQ and in case of any adverse reaction reported in the Hospltal
during administration of the drugs.
VI
C CATEGORY' C' DEFECT (Minor Defects)
I. If single item/ Batch of item is declared NSQ under Category C

. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries
to be initiated by the DDO's wherever payment had been made already.
. Forfeiture of Performance Security from the respective DGESIC Rate Contract
for that drug.
. Rate Contract Holder/ Pharmaceutical flrm will be debarred for futher supply of
the said NSQ item in the currency of the Rate-contract. ..-,,- .r .:-.,.
o Rate Contract Holder/ Pharmaceutical firm Will -be liable to pay damages/
compensation (if any) to individuali individuals arising due to consumption of
item declared NSQ and in case of any adverse reaction repod€jd in the'Hospital
during administration of the drugs.
u. If more than one item ing to any individual
pharmaceutical firm i NSQ u C within a year
Recall of the N nits. Recoveries
to be in already.
Fofeitu Security Rate. Contract
for all the rugs.
supply of
a from
ages/
of
ospital
24.
a. Delivery of si weeks from of the P.O. sent
by email a in stipulated
time.
b. If the pharmaceutical firm esupply order within the

stipulated period of six weeks, a penalty of two (2) per cent of the va lue of
the order catculated at the contract rate per week or a part of a week wi ll be
levied. The maximum for late 10% of the
total extension of
the d ding Officers,
if it a itu I extension is
permissible for a maximum period of 5 week only but penalty will be levied.
VII
c. In case of failure to supply, the Corporation reserues the right to purchase
the stocks from other sources as risk purchase, i.e' purchase from any other
pharmaceutical firm or firms, in the rate contract or from outside the contract
at the discretlon of the Direct Demanding Officer concerned at a competitive
rate or from local chemist.
That extension of deliverv oeriod cannot be claimd as a malter of

rioht but will be at the discretion of con@med cttricen
d If the iterns/ drugs are n ot suppli d (as i ndicated above

or by the ,extended 'date ) full o1 ect of,lhe quantity
not suppiieii is iable to be
I the sk an d expense of
pharmaceutical firm. The extra expenditure involved in procuring supplies
from elsewhere i.e. Local Pu rm/other running Govt. Contract etc',
in that case, will be utical firm, in full at
thus due will be
Officer or which at
or any other
He will be
tion in
n, the
bidd deposit invite
other from Rate
e ree
ntry
next
gof
25. Quoting L'
a.
edule
rges.
b. GST, if extra, where legally leviable and intended to be claimed, should be

distinctly shown separately alongwith the price qu.oted.. where this is not done,
no cfaim of GST will''be aamtea at anyt tatAi stdile 6iiQ on any ground
whatsoever,
\NII
26. Pavment
Payment for the supply will be made within 4 to 5 weeks (after receipt and
aiieptance of the diugs/items) directly by the Direct.Demanding Officers or
or
through nominees to w6om bills are submitted. Notwithstanding any omission
in"riC'o.i.g in the supply order it is incumbent upon the pharmaceutical
fii./UtOaeito supply the items as per the specifications of the relevant rate
after the
coniract. No claim ior the payment from contractor shall be entertained
lapse of three years of arising of the claim.
27. Any dues or payments that have arisen to the Corporation from the
pharmaceuticalfirmforwhichnospecifictimelimithasbeenlaiddowninthe
such time
terms and conditions shall be payable by the pharmaceutical firm within
limitasmaybeprescribedintheletters/ordersaddressedtothepharmaceutical
firms.
Any payments that have been demanded as per the provisions of

above
28,
mentionedclauseorunderanyotherclauseshallbepayablewithinthetimelaid
down. On failure to do so: -
items/
. The pharmaceutical firm shall be liable to be debarred for supplying
years'
drugi etc. to the Corporation for a period not exceeding three
. The Corporation reserves its right to take appropriate legal action

for
against.the
compensation
;;f;rlti;g fiils as may be le{ally advised, including claim
unJaurig.t for the period oldelay and / or simple interest 10o/o per annum
for each daY of default'
29. RateSchedulealongwithlistofitem.wisefinalizedrates,alongwith.nameofthe
rates of more than one firm
;;;;";;; nrr* is ericlosed. In regard to items where firm
nll. U... .pptoved, order shouli be placed to the by such at First Preference and
whose rates are the lowest. In case oi non-supply
firm, order shall be
pf.i.J t" tn" firm with the next higher approved rate invoking risk purchase'
No other document should be entertained for
giving any cognizance for placing the
30.
supply orders.
31. Acceptance letter issued to the firms by this office cannot be used for placing
orders.
32 it"t!N, under Ministry of Labour'& employniEnt has granted exemption .to
per Minutes o-F^the
operaie'OCSfC Rate Contract for drugs and dressings as
nieeting vide office Memorandum no. z-i0025 l25l2ol7-Adm
II dated 29.01.2021.
IX
33 - -ifMajeure:
Force
rf .ny time during the applicability of Contract the bidder fails to discharge its
OUfiguiion due to f6rce maieure (natural disaster. or act of God etc') he
will
p.,ipuv notify the Director'General or its representative about the happening of
iuctr'an eveni. The Director General or its representative is solely engtlqd to
i"*init"l determine the order/contract in respect of suchtheperformance of .the-
contract on behalf
UiaO"rirl'oUfigutlons if he so desires. The obligations under
of biddei for the contract shall be resumed as soon as practicable after the event
has come to an end or ceased to exist.
34 It shall ity of of
In
drug
level with strict control as per ABC-VED matrix and
formutary of the respective institution is followed in right earnest to
provide medical services to
This issue with the a
Yours faithfullY,
Encl.: As above.
/<
Dy. Medical Commissioner(RC)
FOT: DIRECTOR GENERAL
Copy tor
s for
1 All Chief Di on9
information to
all DDOs u
send the list
2 PPS/PS to Di
3 PPS/PS to Fi
PPS/PS to Medical
I Education /
4
Medical Administration
5 Accounts Branch -V (Hq
Dv. Medical Commissioner (RC)

Forr DTRECTOR GENERAL
202L-2023
x
Approved Vendor List 143C
SNo, Name of the Firm
1 Abbott India Limited
2 Healthcare Limited
3 Baxalta Bioscience Ind ia Private Limited
4 Baxter
5 Bharat m
6 Boeh In heim India Private Ltd
8 Ci Limited
9 P
10 Emcure
11 FDC Li
tz
13
t4 Hab
15 Hindustan
16 Intas
luggat Pharma
77 Pharma D of leI
18 Lark Laboratories ndia Ltd.

'l
19 Macleods Pharma
20 Ltd
2L Mesmer Pharmaceuticals
22 Micron Pharmaceuticals
Page 1of 3
SNo. Name of the Firm
23 Midas G re Pharmaceuticals ht. Ltd.
24 Modi Mund Prlvate Limited
25 Overseas Healthcare h/t Ltd
26 Pfizer Lim
27 Pfizer Prod
28 Precise Chemi AA Ltd
29 (aIl India
30 Pulse
31 Revat La )rar(
32 Roche
33 iPa
34 Sanofi -
35 Sanofi I
36 Serdia
37 tatt
38 Sun Pharma La
39 Tablets Limited
40 Themis Medicare Limited

*
47 Troikaa Pha
r
42 USV Private Lim
43 Virchow Biotech h/t. Ltd
44 Wallace Pha rmaceutica ls h/t. Ltd.
45 Windlas Biotech Private Limited
46 Zenith h . Ltd.
Page 2 of 3
SNo, Name of the Firm
47 Zim Laboratories Limited
48 Zuventus Healthcare Limited
49 S care Ltd
rs*t Kffi r43{c}
Page 3 of 3
vendor Name Term 1 Delivery within 6(six) weeks (of the actual date
ABBOTT INDIA LIMITED of dispatch) of supply order on FOR Destinatlon
basis
3 Corporate Par( Sion Trombay Term 2 GST as applicable will be extra except for items
Road, Chembur Mumbai 400071 where no tax has been approved.
Term 3 If at any time documents submitted/
Mobile/ Tel No:9987072315 / information given by the flrm in the tender is
(91-22) 38160s27 found to be false/ erroneous, the award will be
cancelled.
Fax No (if any): (9 1-22) 38162401 'Teim 4 Supply to be made direcUy.
Email: institution.busin ess@abbott.com
Vendor Name Term 1 weeks (of the actual date

BA]AJ HEALTHCARE LI er on FOR Destination
602-606, 6th Floor, Term 2 except for items

Infotech Park, Plot where no
No. 23, Above I
Industrial Estate,
'Term 3 submitted/
Mobile/ Tel tender is
022-66t77400 will be
Fax No (if any): Term 4 lirectly.

Email:
Vendor Name Term 1 (of the actual date

BAXALTA BIOSCIENCE I order on FOR Destination
PvT. LTD
6th Floor, Building no. 8, Tower C, Term 2 GST as applicable will be extra except for items
DLF Cyber City, DLF Phase II,. where approved.
Gurgaon 122002 Haryana
Term 3 documents submitted/
Mobile/ Tel No: 8448815 s63 I n s the firm in the tender is
0124-4559100 found to be false/ erroneous, the award will be
cancelled.
Fax No (if any): 0125-4559109 Term 4 Supply to be made directly.
Emailt tenders.india@takeda.com
Page 1 of 17
Vendor Name Term 1 Delivery within 6(six) week (of the actual date
BAXTER INDIA PRIVATE of dispatch) of supply order on FOR Destination
LIMITED basis
5th Floor, Tower-A, Building No. 9, Term 2 GST as applicable will be extra except for items
DLF Cyber City, DLF Phase III, where no tax has been approved.
Gurgaon-122002, Haryana
Mobile/ Tel No:9810592367 / information given by the firm in the tender is
0Lz4-4200200 found to be-false/,erroneous, the award will be
cancelled.
Fax No (if any): 0tZ4-+20020 Term 4 Supply to be made direcdy.
Email: rahul-gupta@baxter.com
baxsolutions India@baxter.com
Vendor Name Term 1 Delivery within 6(six) weeks (of the actual date
BHARAT SERUMS AND of dispatch) of supply order on FOR Destination
VACCINES LIMITED basis
3rd Floor, Liberty Tower, Behind Term 2 GST as applicable will be eara except for items
Reliable Plaza, Airoli, Navi Mumbai - where no tax has been approved.
400708
Mobile/ Tel No: 9910025803 / information given by the firm in the tender is
cancelled.
Email:
vishwadeep,srivastava@bharatserums.com
sandeep.shinde@bharatserums.com
institution@bharatserums.com
sunny,bhardwaj@bharatserums.c0m
Vendor Name Term I Delivery within 6(six) weeks (of the actual date
BOEHRINGER INGELHEIM of dispatch)-of supply order on FOR Destination
INDIA PRIVATE LTD basis
1102, 11th Floor, Hallmark Business Term 2 GST as applicable will be extra except for items
Plaza, Gurunanak Hospital Road, where no tax has been approved.
Near Gurunanak Hospital, Bandra -,,.,':..
East, Mumbai, India - a0005,f..,
.Terrh 3 If :
at .. ahy tirne.'.. documents su bmitted/
9t-22-26456477 found to be false/ erroneous, the award will be
9t-22-7t456477 cancelled
Fax No (if any): 9I-22-71456766 Term 4 Supply to be made directlY.
Email: ratan.sharma@boehringer-
ingelheim.com
Pmibtender.in@boehringer-ingelheim.com
Page 2 of L7
CENTAU R PHARMACEUTICALS of dispatch) of supply order on FOR Destination
PvT. LTD. basis
Centaur House, Shanti Nagar, Term 2 GST as applicable will be extra except for items
Vakola, Santacruz East, Mumbai - where no tax has been approved.
400055.
Mobile/ Tel No:' 9820244293 I information given by the firm in the tender is
02266499270 /0 ..founQjo be false/ erronequs, the award will be
IC
cancblled.
Fax No (if any): iTerniS Supply- to be made directy.
Email: institutions@ .com
sameer@centaurlab.com
Vendor Name Term 1 /eeks (of the actual date

CIPLA LIMITED rrder on FOR Destination
Cipla House Pen Term 2 GST r except for items

ParK Ganpatrao 'ed.
Parel, Mumbai-
,.Term 3 submitted/
Mobile/ Tel N tender is
8874450173 I rd will be
022 24826000
Fax No (if any) Term 4
Emaill
manish.s@Cipla.com
Vishwas.Ahuja@Cipla
Vendor Name Term 1 weeks (of the actual date

Concept Pharmaceuticals su pply order on FOR Destination
Limited s
801, Hubtown Solaris (entrance Term 2 GST as applicable will be extra except for items
From B Wing) N S Phadke Miirg, Off where notax has been approved.
Teli Galli, Near Andheri Flyover,
Andheri (East), Mumbai-400069 11" If
Term 3 at any time documents submitted/
Mobile/ Tel No: 9891249600 / information given by the flrm in the tender is
022- 42418888 found to be false/ erroneous, the award will be
cancelled.
Fax No (if any): 022- 42418888 Term 4 Supply to be made directly.
Email: saniay.vasudeva@yahoo.com
concept.pharmaltd@gmail.com
Page 3 of 17
EMCURE PHARMACEUTICALS of dispatch) of supply order on FOR Destination
LIMITED basis
Survey No. 255/2, Phase I, Rajiv Term 2 GST as applicable will be extra except for items
Gandhi IT Park, MIDC, Hinjawadi, where no tax has been approved.
Pune - 411057
Mobile/ Tel No: 9370130077, n the tender is
9830890292 174 287t433j award will be
020 39821000
Fax No (if any): 020 39821020 Terrh 4- SupDli to be re(
Email: nitind@emcure.co.in
niladri.das@emcure.co,in
anil.arora@emcure,in
Vendor Name Term 1 ks (of the actual date

FDC LIMITED 3ron FOR Destination
142-48, S.V. Term 2 xcept for items

(West) 400102 L
Term 3 submitted/
Mobile/ Tel No: 8652684108 e tender is
I 8554925907 97-22 267 3937 7 rd will be
Fax No (if any): 022-26773462 Term 4 ctly.

Email: tenders@fdcindia.com

Gennova Biopharmaceticals Ltd order on FOR Destination
Survey No. 255/2, Phase I, Rajiv Term 2 GST as applicable will be extra except for items
Gandhi IT Park, lvlIDC, Hinjawadi, where no tax has been approved.
Pune - 411057
Terii,r 3 If .-tatr: any .rtime documents submitted/
Mobile/ Tel No: 9370130072, information given-by the firm in the tender is
9970009897 /9830890292, found to be false/ erroneous/ the award will be
7 4287 74333I 020 39821000 cancelled.
Fax No (if any): 020 39821020 Term 4 Supply to be made directly,
Email: anil.arora@emcure.in
nitind@emcure.co.in
satyajit.paul@emcure.co.in
Page 4 of L7
GOPAL DAS VISRAM AND of dispatch) of supply order on FOR Destination
COMPALNY LIMITED basis
8, Fida Building, 18 Shamaldas Term 2 GST as applicable will be extra except for items
Gandhi Marg, Dawa Bazar, Mumbai : where no tax has been approved.
400002
Mobile/ Tel No: 98 n n the tender is
award will be
C
022-2240t7281 99
ca
Fax No (if any): Term 4 Supplfto be mate directli.'
Email: taxationdept2ol6@gmail.com

HAB on FOR Destination
RESEARCH LTD
308 3rd Floor T.v Industrial Estate Term 2 pt for items

S. K Ahire Marg Worli Mumbai 30 wheft
erm 3 If at any submitted/
Mobile/ Tel No: 9930212908 / tender is
022-66267409 rd will be
Fax No (if any): Term 4 Supply to be made directly.

Email: marketing@

HINDUSTAN LABORATORIES order on FOR Destination
LIMITED
A-302, Victory Park, Chandavarkar 2 GSI as.applicable.Will be extra except for ite ms
tTgrm
Road, Borivall (West), lYumbai - where no tax has bedn approved.
400092, Maharahstra
Term 3 Ifata documents submitted/
98207 87 s58I 02242460500, found to be false/ erroneous, the award will be
42460526 cancelled.
Fax No (ifany): 022-42460531 Term 4 Supply to be made directly.
Email: tender@hindlab.com
kunjaldedhia@hindlab,com
Page 5 of 17
INTAS PHARMACEUTICALS of dispatch) of supply order on FOR Destination
LIMITED basis
Corporate House, Near Sola Bridge, Term 2 GST as applicable will be extra except for items
S.G. Highway, Thaltej, Ahmedabad- where no tax has been approved.
380054
Mobile/ Tel No: 932802s602 I n the tender is
079-39837000 award will be
Fax No (if any): Term 4 Supply to be made dirbctly.

Email: ketan_shah@intaspharma.com

Juggat Pharma FOR Destination
Division of
Private Limited)
No.782, 15th Term 2 GST as applicable will be extra except for items
J.P.Nagar, where no tax has been approved,
Bangalore - 560
Term 3 If at any time oo( submitted/
Mobile/ Tel No information given by tender is
26635026, found to be false/ erroneous/ award will be
cancelled,
Email:
tenders@jagdale.com
LARK LABORATORIES (INDIA) of dispatch) of supply order on FOR Destination
LTD. basis
A-105 12, Okhla Industrial Term 2 GSf;arppiicable wiil be extra except for items
Phase-Il. New Delhi-110020 where no tax has been
0tt-407L7777 found to be false/ erroneous, the award will be
cancelled.
Fax No (if any): 9l-7492-225137 Term 4 Supply to be made directly.
Email: tender@larklab.com
larklab@gmail.com
Page 5 of 17
MACLEODS PHARMACEUTICALS of dispatch) of supply order on FOR Destination
LIMITED basis
Atlanta Arcade, Marol Church Road, Term 2 GST as applicable will be extra except for items
Opposite Leela Hotel , Andheri where no tax has been approved,
(East), Mumbai - 400059
Mobile/ Tel No: 8 I the tender is
98678680021 022 award will be
Fax No (if any): 0 Term 4 Supply to be made directly.

Email: tendem@macleodspharma.com
oshukla@macleodspharma,com
Vendor Name Term I (of the actual date

MEDLEY FOR Destination
LTD
Add - Medley ho Term 2 G.ST as applrc for items

Andheri (E), Mu where no tax h
Term 3 submitted/
Mobile/ Tel Not 93222M643 I e tender is
982103 1003/022 687 57 57 5 rd will be

Email : tdkkrishna@gmiil.com
arshad.jafferey@medleylab.com
Vendor Name Delivery within 6(six) weeks (of the actual date
MESMER PHARMACEUTICALS of dispatch) of supply order on FOR Destination
basis
Vedha No 13, Mangala N 2 GsTiatappliciiUlel^iill be extra except for items

::Term
Main Road, Porur, Chennai- w.lerelo91nas b€qt approved.
600116,Tamil Nadu.
Mobile/ Tel No: 9444903427 I information given by the firm in the tender is
cancelled.
Email: gvsmani.mesmer@iconlife.in
tenders.mesmer@iconlife,in
Page 7 of 17
MICRON PHARMACEUTICALS of dispatch) of supply order on FOR Destination
basis
Plot no 2117 A-2 Phase III GIDC Term 2 GST as applicable will be extra except for items
Vapi 396 195 where no tax has been approved.
Mobile/ Tel Nor 9924170750 / information given by the firm in the tender is
9820081388/ 0260 74054001 found to be false/ erroneous, the award will be
0s106107 cancelled.
Fax No (if any): 0260 2405479 Term 4 Supply to be made direct]y.
Email: contactus@micronpharma.ln
sales@m icronpharma.in
vendor Name Term 1 Delivery within 6(six) weeks (of the actual date
MIDAS CARE of dispatch) of supply order on FOR Destination
PHARMACEUTICALS PvT. LTD basis
Lotus Corporate Par( B Wng, 3rd Term 2 GST as applicable will be extra except for items
Floor, Jay Coach, Graham Firth where no tax has been approved.
Compound, WE Highway, Goregaon
(East), Mumbai 400063
cancelled.
Email: nandan@midas-cire.com
tender@midas-care.com
MODI MUNDIPTIARMA PRIVATE of dispatch) of supply order on FOR Destination
LIMITED basis
, l.l ,lrI'\ar-t
1400, MODI TOWER, 98, NEHRU Term 2 GST' as applicable will be extra except for items
PLACE, NEW DELHI-110019 where no tax has b€en approved.
011-4250 4555, 011 4250 4992 found to be false/ erroneous, the award will be
cancelled.
Fax No (if any): 011-2645 1659 Term 4 Supply to be made directly.
Email: pmd@modimundipharma.com
arvindmadan@modimundipharma,com
Page 8 of 17
OVERSEAS HEALTH CARE PvT. of dispatch) of supply order on FOR Destination
LTD. basis
335Km Milestone, National Highway Term 2 GST as applicable will be extra except for items
No.1, P.O. Box 25, Phillaur, District where no tax has been approved,
Jalandhar, Punjab State
07826-222886 ,found.to be felse/ erroneo-us, the award will be
cancelled. ' i
Fax No (if any): 07826-222885 'Ter.!:nt Supply'to be made directly.
Email: info@overseasheil$rcarri.io.in
dmohcpl@gmail.com
Vendor Name Term 1 eeks (of the actual date

PFIZER LIMITED rder on FOR Destination
The Capital 1802/ Term 2 r except for items

70, G-Block, Ba red.
Bandra (E) Mum
Term 3 submitted/
Mobile/ Tel tender is
97714t47561 found to be false/ will be
Fax No (if any) 4

Email:
Rajesh.kadian2@pfizer
Satendra.seth@pfizer
Vendor Name Term L Ddlivery within 6(six) week (of the actual date
PFIZER PROCUCTS INDIA PVT of dispatch) of supply order on FOR Destination
LTD basis
The Capital 1802/1901, Plot No. C- aar.T 7 for items

70, G-Bloc( Bandra Kurla Complex, approved,
Bandra (E) Mumbai - 400051
Term 3 If at any time documents su bmitted/
Mobile/ Tel No: 9771414156 i information given by the firm in the tender is
2266932000 found to be false/ erroneous, the award will be
cancelled.
Email:
GOVERNN4ENTTENDERSPPIPL@pf izeT,com
Rajesh.kadian2@pfizer.com
Satendra.seth@pf izer,com
Page 9 of 17
PRECISE CHEMIPHARMA of dispatch) of supply order on FOR Destination
PvT.LTD basis
Offlce No. D-4, Neelkanth Business Term 2 GST as applicable will be extra except for items
Park, Nathani Road, Vidyavihar where no tax has been approved.
(West), Mumbai - 400 086
Mobile/ Tel No: 98191-49266 / information.given ,by the fffn jn the tender is
91-22-68783333 ., t, found to bdftlse/ brrdnq0us, tlie award will be
cancelled.
Fax No (if any): 91-22tir83333 Terit 4' Su pply to be made directly.'
Email : tenders@precisegroup.co.in
Vendor Name -.:.

Term I livery within 6(six) week (of the actual date
PSYCHOTROPICS II{DIIA] of dispatch) of supply order on FOR Destination
LIMITED basis
Plot No. 17, Sector- 20 A, Term 2 G pt for items

Faridabad-121001
Te rm3 If at any time documents submitted/
information given by the firm in the tender is
0t29-228269t found to be false/ erroneous, the award will be
cancelled,
Fax No (if any): 0L?9-2296764 Term 4 Supply to be made direcUy.
Email: kapoorsatishT2@yahoo.com
Vendor Name r',t; Term 1 6(six) week (of the actual date
PULSE PHARMACEUTICAT PVT supply order on FOR Destination
LTD basis
Plot No: 18/1, Sector III, HUDA Term 2 G,ST as applicable will be extra except for items
Techno Enclave, Hitech City, .: - where.no tax has been approved.
Hyderabad - 500 081.
Term 3 If at
any ttme documents submitted/
Mobile/ Tel No: 9346155755, information given by the firm in the tender is
9311083087 / found to be false/ erroneous, the award will be
97-40-23t79992 cancelled.
Fax No (if any): 91-40-23119992 Term 4 Supply to be made direcfly.
Email: suresh@pulsepharma.net
dineshkumar@pulsepharma.net
Page 10 of 17
REVAT I.ABORATORIES PvT. of dispatch) of supply order on FOR Destination
LTD, basis
8-2-700, Srida Anushka Pride , Road Term 2 GST as applicable will be extra except for items
No.12, Banjara Hills, Hyderabad - where no tax has been approved,
500 034
f submitted/
Mobile/ Tel No: 98q5t215ss / the tender is
040-23097936
.-.,:'. ,It:" award will be
ca
Fax No (if any): 0091-040- **,1 Supply to be made directly.
23095071
Email: anilminol23@gmail.com
Vendor Name Term 1 the actual date

Roche Products (India) Pvt.Ltd. R Destination
na,
146-8, 166 A, Unit No. 7,8,9,8th Term 2 GST as applicable will be extra except for items
Floor, R City Office, R City Mall where no tax has been approved.
Lal Bahadur Shastri Marg,Ghatkopar,
Mumbai - 400 086
Term 3 If at submitted/
Mobile/ Tel ths firm in the tender is
97 22 50457300 award will be
candelled.
Fax No (if any): 9 Term 4 Supp[l to be niade directly.
Email: nernelin
rajenderan.krishnamu
SAI PARENTERALS PvT LTD of dispatch) of supply order on FOR Destination
basis
8-2-700, Srida Anushka Pride , Road . Term 2 GST aiapplicable'will be extra except for items
No.12, Banjara Hills, Hyderabad - where no Ex has bd4r approved.
500 034
040-23097936/9848237 737 found to be false/ erroneous, the award will be
cancelled.
Fax No (if any): 0091-040- Term 4 Supply to be made directly.
23095071
Email: md.saiparenterals@gmail.com
saiparenterals@gmail.com
Page 1l of 17
Sanofi - Synthelabo (India) of dispatch) of supply order on FOR Destination
Private Limited basis
Sanofi House, C.T.S No.117-B, L&T Term 2 GST as applicable will be extra except for items
Business Park, Saki Vihar Road, where no tax has been approved.
Powai, Mumbai - 400 072
916790s0091 022 0i20 .found to be false/ erroneous. the award will be
iancelled. ' '
Fax No (if any): 02 9 Term 4 Supplv'to be made directly.
EmaiI institution.busin ,com
institution.business@sanofi.com
vendor Name Term 1 eeks (of the actual date

SANOFI INDIA LI rder on FOR Destination
Sanofi House, C.T. Term 2 tra except for items

T Business Parl! oved.
Powai, Mumbai -
Term 3 submitted/
Mobile/ Tel No:9312403063 / the tender is
9167905009/ 022 28032000 award will be
cancelled.
Fax No (if any): 022 28032939 Term 4 Supply to be made directly;
Email: institution.business@sanofi.com
institution.business@sanofi .com
Vendor Name Term 1 ks (of the actual date

SERDIA order on FOR Destination
PHARMACEUTICAL(INDIA)
PvT.LTD
1703, 17th Floor, Parinee Crescenzo, Term 2 GST as applicable will be extra except for items
'B' Wing, Plot Nos. C 38 & 39, 'G" wlidre no-tatrhe biieh approved,
Block, Behind MCA, Bandra Kuila .i'
Complex, Bandra (East), Mumbai -
400051.
022 - 68100700 found to be false/ erroneous, the award will be
cancelled.
Emai!: m.gurulingam@servier.com
serdia.sales@servier.com
Page 12 of 17
SIGNATURE PHYTOCHEMICAL of dispatch) of supply order on FOR Destination
INDUSTRIES basis
310, 3rd Floor T.V Industrial Estate Term 2 GST as applicable will be extra except for items
S.K Ahire Marg Worli Mumbai 30 where no tax has been approved.
022-66261400
Fax No (if any): 022-66241.41 (

\
J
r)l
Term 4
found to be false/ erroneous, the award will be
cancelled.
Supply to be made directly.
Email : marketing@signaturepi.in
marketing@habpharma.in
Vendor Name Term 1 Delivery n 6(six) weeks (of the actual date
SUN PHARMA LABORATORIES of dis of supply order on FOR Destination
LIMITED basis
Sun House, 201 B/1, Western Term 2 GST as applicable will be extra except for items
Express Highway, Goregaon East, where no tax has been approved.
Mumbai - 400063
Term 3 if at any time documents submitted/
022 4324 4324 found to be false/ erroneous, the award will be
cancelled.
Fax No (if any): 022 4324 4343 Term 4 Supply to be made direcdy.
Email:
hemantakumar,meher@sunpharma.com
Vendor Name Term I Delivery within 6(six) weeks (of the actual date
TABLETS (INDIA) LIMITED of dispatch) of supply order on FOR Destination
basis
# 72, Marshalls Road, "Jhaver

) Term 2 GST as applicable will be extra except for items
Centre" R A Building, 4th Floor, ( where no tax has been approved.
Egmore, Chennai - 600 008 ' t
0zl4 - 42050186 found to be fulse/ erroneous, the award will be
cancelled.
Fax No (if any): 044 - 28589090 Term 4 Supply to be made directly.
Email : hd@tabletsindia.com
Page 13 of 17
THEMIS MEDICARE LIMITED of dispatch) of supply order on FOR Destination
basis
lU 12,Udyog Naga r,S.V. Road, Term 2 GST as applicable will be extra except for items
Goregaon(W),M umbai-400 104 where no tax has been approved.
91-22-67607080 found to be false/ erroneous, the award will be
...ca ncelled .
Fax No (ifany): g!-22:'. , i Term 4

6760707012874662t
Email: instmgr@ttremismedicare.com
Vendor Name Term 1 Delivery within (of the actual date

TRIOKKA PHARMACEUTICALS of dispatch) of on FOR Destination
LIMITED basis
Commerce House-1, Satya Marg, Term 2 GST as applicable will be-e*ra except for items
Bodakdev, Ahmedabad - 380054 where no tax has been approved.
07 9 -268s6242I 43 I 44 I 45 found to be false/ erroneous/ the award will be
cancelled.
Fax No (if any): 079-26856246 4 Supply to be made directly.
Email: head-inst@troikaapharma.aom
tenderorder@troikaaphama.com
Vendor Name Term 1 ry with n 6 ( tx) wee ks ( of t he a ctua d ate

USV PRIVATE TIMITED d ispatch of u p p ly o rder o n FO R De sti nati o n
Arvind Vitthal Gandhi Chowk, B.S.D Term 2 GST as applicable will be extra except for items
Marg, Govandi Station Road, wh9.!'e ta X nl.. approved.
!.,t9...
Mumbai - 400088
Mobile/ Tel No:9004084309 /

Teriir 3 If at ti mt docu m nts s u b m itted
iriform ati n s ve n by t he fi rm n t h te nder S
987 159 49 46 I 022 255 64048 found to be false/ erroneous, the award will be
cancelled.
Fax No (if any): 022 25584025 Term 4 Supply to be made directly.
Email: manoj.sharma@usv.in
chhotelal.tiwari@usv.in
Page L4 of 17
VIRCHOW BIIOTECH PvT LTD of dispatch) of supply order on FOR Destination
basis
Plot No. 319 & 320, 3rd Term 2 GST as applicable will be extra except for items
FloorSwamyAyyappa Co-op. Housing where no tax has been approved.
Society, Madhapur, Hyderabad 500
081
Mobile/ Tel Nor information given by the firm in the tender is
8879110909/097000u€?0 / fo u n d to be.fals el er ron eollt the award will be

+91-40-23119481 ca nci:lled
+91-40-23119486 .a,
Fax No (if any): Fax No: Term 4 Supply to be made directly
23119486.
Email: shambhu.s@virchowpharma.com
sham bhu.s@virchowpharma.com
Vendor Name 'Term 1 ry within actual date

WALLACE PHARMACEUTICATS of dispatch) of Destination
PVT. LTD basis
A 303/312 Floral Deck Plaza; Off term z GST as applicable will pt for items
Central MIDC Road, Andheri (East), where no tax has been approved.
Mumbai-400093
Term 3 I t .at an docu m submitted/
Mobile/ Tel No: nformation g Men he firm tn the tender is
9820360019i981112970t I fou nd to be fa se/ the award will be
022-68311100 ca
Fax No (if any): 022'28390733 Term 4 Supply to be made directly.
Email: p;avinwani@wallaceoarma.net
institution@wallacePharma.net
ms379@hotmail,com
Vendor Name term I Delivery within 6(six ) WC ks ( of t he a ct ua d ate

I
WINDI.AS BIOTECH PRIVATE d s U p p ly o rder o n FO R De sti n ati o n

LIMITED basis
705-706, Vatika Professional point, Term 2 GST as applicable will be extra except for items
sector-66 golf course ext, road, & where no tax has approved.
Gurgaon-122001 Haryana a
'-Term 3 If at a me documents submitted/

t24-2821030 found to be false/ erroneous, the award will be
cancelled
Fax No (if any): 124-2821060 Term 4 Supply to be made directlY.
Email:
institutionalhead@windlasbiotech.com
Page 15 of 17
ZENITH DRUG PvT LTD of dispatch) of supply order on FOR Destination
basis
7215 Muradpura(OrangPura) Dhar Term 2 GST as applicable will be extra except for items
Road Near Kalaria Indore M.P. Pin where no tax has been approved.
453001
843s501867 fo u n d to be ls el er ron uglr*, th e a wa rd I be I
ca n ce I led
Fax No (if any): 073L-2435123 5u p be made.d recty
Emaili info@zenithdrugs.com
Zim Laboratories Limited of dispatch) of supply order on FOR Destination
basis
B-2U27, MIDC Area, Kalmeshwar- Term 2 GST as ap p i except for items

441501 Dist. Nagpur whe
3 If ti submitted/
Mobile/ Tel No: 9818678219 information by in th e tender is
/9823089 1 2sl 07 118-27 147 0 | 480 found to be false/ erro neous, the award will be
cancelled,
Term 4 Supply to be m
Emaill adminot@zimlab.in'
tendercell@zimlab.in
riaz. ka ma I *6zim lab. n
i
Vendor Name 1 Delive ry n 6(s wee ks (of the actual date

ZUVENTUS HEALTHCARE u p p ly o rde I o n FO R Desti na ti o n
LIMITED basis
Office No. 5119, 5th Floor, D Wing Term 2 GST as a pplicable will be extra except for items
Oberoi Garden Estates, Chandivali; whele 1o tax'has been approved.
Andheri (E), Mumbai 400 072.
022 3061 0000 found to be false/ erroneous, the award will be
cancelled.
Fax No (if any): 022 2847 2829 Term 4 Supply to be made directlY.
Emai!: nilesh.nabar@zuventus.com
Sheetal.khanvilkar@zuventus.com
Page 15 of 17
ZYDUS HEALTHCARE UMITED of dispatch) of supply order on FOR Destination
basis
Scheme No. 63, Survey No. 536, Term 2 GST as applicable will be extra except for items
Khoraj (Gandhinagar), S,G. where no tax has been approved.
Highway, Nr. Vaishnodevi Circle,
Ahmedabad-382481
Teim 3 submitted/
Mobile/ Tel Nor 98 11303727 I fi the tender is
079-26868100 be award will be
cancelled.
Fax No (if any)r 079-26868100 Term 4 Supply to be made directly.
Email : sandeep.sarkar@zyduscadila.com
Page L7 ol L7
Index 143C
SNo Item Item Description Page

No. no
Bronchodilator Syp-
Each 5ml to contain: Theopyllin Ethanoate Of Piperazine 80m9,
Eph. Hcl.12mg, Guaiphenesin 50m9, Alcohol 0.55m1, Absolute
I 33 Alcohol Content 10.44 o/o. 1
Frusemide Tab/Gp-
z 60 Each Tab/Gp to contain: Frusemide 40mg 1
Isoxsuprine Inj-
3 63 Each ml to contain: Isoxsuprine 5mg 1
Heparin Sodium Inj-

4 7t Each ml to contain: Heparin Sod. 5000 IU II 1
Flunarizine Tab/Gp-
5 75 Each Tab/Cap to contain: Flunarizine 10mg 7
Fluoxetine Tab/Cap-
6 97 Each Tab/Gp to contain: Fluoxetine 20mg 7
Phenytoin Sodium Tab/Cap-
7 98 Each Tab/Cap to contain: Phenytoin Sodium 100ms 2
Trihexyphenidyl Tab/Cap-
I 103 Each Tab/Gp to contain: Trihexyphenidyl Hydrochloride 2mg 3
Budesonide Inhaler- I
9 362 Each Metered Dose to contain : Budesonide 100 mcg 3

Losartan+Hydrochlorthiazide Tab/Cap-
Each Tab/Cap to contain: Losartan Potassium 50 mg,
10 365 Hydrochlofthiazide 12.5 mg 3
Fenoflbrate Tab/cap-
11 367 Each Tab/Cap to contain: Fenofibrate ( Micronised ) 200 mg 4
+
Ipratropium Salbutamol Inhaler-
Each l4etered Dose to contain: Ipratropium I.P.20mcA.,
12 421 Salbutamol LP. ioomcg 4
Amiodarone Tab/Gp-
13 422 Each Tab/Cap to contain: Amiodarone Hcl 1Q omg 4
I
Indapamide SR Tab/Gp-
L4 425 Each SR Tab/Cap to contain : Indapamide 1.5 mg ls
Clopidogrel Tab/Cap-
15 429 Each Tab/Cap to contain: Clopidogrel 75mg 5
fianeptine Tab/Cap-
16 47t Each Tab/Cap to contain: Tianept ine Sodium 12.5m9 5
Ipratropium Resp. Soln-
17 481 Each ml to contain:I ratro um Bromide 250 m 6
Etophylline & Theophylline Syp-
18 516 Each 5 ml to contain: h line 45.5 Theo lline 14m 6
Cough Sedative Syp-
Each 5ml to contain: Chlorpheniramine Meleate 2.5m9,
i9 518 Guai enesin 100 Nosca ine 15m Sodium Citrate 60 m 6
Tranexamic Acid Tab/Cap-
20 521 Each Tab Ca to contain: Tranexamic Acid 500m 7
Tranexamic Acid Inj-
21 s22 Each 5ml to contain: Tranexamic Acid 500m 7
Page 1of 8
Index 143C

No. no
Sulbutiamine Tab/Gp-
22 540 Each Tab/Gp to contain: Sulbutiamine 200m9 7
Fluticasone+Salmetrol Rotacap-
Each Rotacap to contain: Fluticasone 250 mca, Salmetrol 50
23 550 mcg 8
Metoprolol Inj-
24 574 Each ml to contain: Metoprolol 1mg 8
Coagulant Solution-
Each ml to contain: Aqueous Solution Of Haemocoagulase
Isolated From Bothrops Atrox Or Bothrops lararaca 0.2CU,
Chlorhexadine Gluconate Soln.0. lpercent (As Preservative),
25 580 Water For Inject i9n Q.s I
Etophylline & Theophylline Tab/Cap-
26 1032 Each Tab/Cap to colltain: Etophylline 77 mg,Theophylline 23 mg 9
Salbutamol + Beclomethasone Inhaler-
Each Metered Dose to contain: Salbutamol 100 mcg.,
27 1041 Beclomethasone Di onate 50 mcg. 9
Pediatric Cough Linctus Syp -
Each ml to contain : Noscapine 1.83m9, Citric Acid 5.8m9, Sod
28 1050 Citrate 0.67m9, Amm . Chloride 7mg 9
Bisoprolol Tab/Cap-
29 1055 Each Tab/Cap to conta in: Bisoprolol Fumerate 5 mg 10
Trimetazidine Ta b/Cap-
30 1063 Each Jeblcap to contain: Trimetazidine Hcl 20 mg 10
Isoxsuprine Tab/Cap-
31 1074 Each Tab/Gp to co ntain: Isoxsuprine Hcl 10 mg 10
Haemo-Coagulant Inj-
Each ml to contaln : Aqueous Solution Of Haemocoagulase (One
I U/CU/NIH Unit) Isolated From Venom Of Bothrops, Jararaca
32 1078 Or Bothrops Atrox Containing Sodium Chloride 0,9% 10
Nimodipine Tab/Cap-
33 t724 Each Tab/Cap to contain : Nimodipine 30 mg 11
Sodium Valproate Tab/Cap -
34 1131 Each Tab/Gp to contain: Sodium Valproate 200mq. 11
Levodopa & Grbidopa Tabi Gp-
2( tt32 Each Tab/Cap to contain: Levodo pa 250 mg, Grbidopa 25 mq 72
Valsartan Tab/Gp-
36 1348 Each Tab c.a to contain: Valsartan 72
l,letolazone Tab/Cap-
37 1349 Each Ta Cap to contain Metolazone 5mg tz
Torsemide Tab/Gp-
38 1370 Each Tab Ca to contain: Torsemide 10m 13
Perindopril + Indapamide Tab/Cap-
Each Tab/Cap to
contain: Perindopril Erbumine 4mg,
39 t372 Indapamide 1.25mq 13
Mefenamic + Tranexamic Acid Tab/Cap-
Each Tab/Gp to contain: Mefenamic Acid 250m9, Tranexamic
40 1393 Acid 500 13
PaBe 2 of 8
Index 143C

No. no
Telmisartan Tab/Cap-
4t t420 Each Tab/Gp to contain: Telmisartan 40mg 74
Perindopril + Amlodipine Tab/Cap-
47 14Zl Each Tab/Cap to contain: Perindropil 4mg, Amlodipine 5mq l4
Hydroxyzine Hydrochloride Tab/Cap-
43 1461 Each Tab/Gp to contain: Hydroxyzine Hydrochloride 25mq I4
Inhaler -
Each Metered Dose to contain: Ipratropium l:}mq,
44 1.522 Levosalbutamol 50mcg 15
Budesonide Respule-
45 t524 Each 2ml to contain Budesonide 1mg Steriod Nebulizing Fluid 15
llotropium Bromide Rotacap-
Each Rotacap to contain :'Iiotropium Bromide IPIBP Eqv. to
z*b '1-iotro
1525 ium Bromide Monoh rate 18 mcg. 16
lvabradine Tab/Cap-
47 1530 Each Tab/Cap to contain: Ivabradine 5mg 16
Olmesartan Tab/Cap-
48 1668 Each Tab/Cap to contain : Ol mesartan 20mg 77
Haemostatic-
Each 5ml to contain: Haemostatic Matrix With Prefilled Gelatin
49 1670 Granules In Syringes 17
Sumatriptan Tab/c.ap-
50 7674 Each Tab/Cap to contain: Sumatri ptan 50mg 18
Citicoline Tab/Cap-
51 1681 Each Tab/Cap to contain: Citicoline 500 mg 18
Divalproex Sod. Tab/Cap-
52 1682 Eac h SR/ER/CR Tab/Cap to contain: Divalproex Sod. 250mq 19
Divalproex Sod. Tab/Cap-
53 1683 Each SR/ER/CR Tab/Gp to contain: Divalproex Sod. 500mq 19
Inhaler-
54 7749 Each Metered Dose to contain: Levosalbutamol Tartrate 50mcg 70
Nebivolol Tab/Cap-
55 1751 Each Tab/Cap to contain: Nebivolol 5mg zo
Tenecteplase 40mg Inj-
56 1752 Each Vial to contain: Tenecteplase 40mg 20
Indapamide SR + Amlodipine Tab/Gp-
I
Each Tab/Gp to contain: Tab/Gp Indapamide SR 1.5 mg,
57 1754 Amlodipine Besylate Equivalent To Amlodipine 5 mg 2t
Inhaler-
Each Delivered Dose to contain: Salmetrol Xinafoate IP
Equivalent to Salmetrol IP 25 trg, Fluticasone Propionate IP I
250p9, Excipients & Propellant 1, 1,1.2 Tetrafluoro Ethane HFA

58 1840 134a 2l
Autohaler-
Each Delivered Dose Of Autohaler to contain: Salmeterol (As
Salmeterol Xinafoate) IP
25 mcg, Fluticasone Propionate IP
250mcA Suspended In Propellant 134a Q.S. (Contains Absolute
59 1843 Alcohol Ip 5olo v/v) 2t
Page 3 of 8
Index 143C

No. no
Metoprolol Succinate SR Tab/Gp-
Each SR Tab/Cap to contain: Metoprolol Succinate 23.75m9
60 1845 uivalent To Meto rolol Tartrate 25m 22
Amisulpride Tab/Gp-
b1 1869 Each Tab/Cap to contain: Amisul pride 50mg 22
Quetiapine Tab/Cap-
62 1870 Each Tab/Cap to contain Quetiapine 25 mg 7?
Quetiapine Tab/Cap-
63 1871 Each Ta Qp to contain: Quetiapine 100 mg 23
Paroxetine CR Tab/Gp-
64 1873 Each CR Tab/Cap to contain: Paroxetine 25m I 23
I Levetiracetam Tab/Cap-
65 1879 I Each Tab/Ca p to contain: Levetiracetam 500mq 24
Levetiracetam Tab/Cap-
66 1880 Each Tab ca to contain: Levetiracetam 250 24
Lamotrigine Tab/Cap-
67 1883 Each Ta G to contain: Lamotr ine 100m 25
Montelukast Sodium Tab/cap-
68 20t4 Each Ta G to contain: Montelukast Sodium 10m 25
I
Beclomethasone Dipropionate IP 200mcg (HFA Technology)
Inhaler-
Each I'4etered Dose to contain: Beclomethasone Dipropionate Ip
69 2015 2Q0mcg (HFA Technology) 25
Indapamide (As SR)1.5m9 , Amlodipine B€silate Equivalent to
Amlodipine 2.5m9, Excepients QS Film Coated Bi-Layered
Tab/Cap- I
Each Film Coated Bi-Layered Tab/Cap Contains: Indapamide (As

SR)1.5m9 , Amlodipine Besilate EquvalentTo Amlodipine 2.5mg,
70 20t9 Excepients QS 26
Acenocoumarol / Nicoumalone Tab/Cap-
77 2022 Each Tab/Cap to contain: Acenocoumarol / Nicoumalone 2mq 26
Ambroxol + Terbutaline Tab/Gp-
Each UncoatedTab/Gp to contain; Ambroxol Hrdrochloride 30
2060 Terbutaline Sul hate uivalent to Terbutaline 2,5 26
Ambroxol + Terbutaline Syp-
Each 5 ml to contain: Ambroxol Hrdrochloride IP 30 mg,
Terbutaline Sulphate IP Equivalent to Terbutaline 2.50 mg,
73 2061 Guaiphenesin IP !0 49, Menthol IP 0.5 mg
Inhaler-
Each Inhaler to contain: Fluticasone Propionate 250mcg,
74 2063 Formoterol Fumarate 6m
SC)Metoprolol Tab/Cap-
Each Prolonged Release Film Coated Tab/Gp to contain : S(-
)Metoprolol Succinate 47.50 mg Eqv. to S(-) Metoprolol Tartrate
75 2067 50m
S(-)Metoprolol TabiCap-
:
Each CR/PR/DR/SR/MR Tayc;,p to contain S(-)Metoprotot
76 2068 Succinate 23.75 m .toS Meto rolol Tartrate 25 z8
Page 4 of 8
Index 143C

No. no
Tlcagrelor Tab/Cap-
77 2069 Each Tab/Cap to contain:Ticagrelor 90mg 28
Ivabradine Tab/Cap-
Each Film Coated Tab/Cap to contain: Ivabradine Hcl Equivalent
78 2070 To IvabradineT.5mq 28
Indapamide + Amlodipine Tab/Gp-
Each Film Coated Bilayered Tab/Cap to contain Indapamide (As
Sustained Release) 1.5m9 and Amlodipine Besilate Equivalent to
79 2074 Amlodipine 10mg 28
Micronised - Purified Flavonoid Tablcap-
Each Film Coated Tab/Cap to contain: Micronised - Purified
Flavonoid Fraction 1000m9-Composed Of Diosmin 900m9
80 7076 (90o/o) And Flavonoids Expressed As Hesperidin 100mq (100/o) 29
Hemostat-
Each PFS to contain: Hemostatic Matrix With Thrombin In
81 2077 Prifilled Syringe 10ml 29
Apixaban Tab/Gp-
82 2078 Each Film Coated Tab/Gp to contain: Apixaban 2.5mq 29
Apixaban Tab/cap-
83 2079 Each Film Coated Tab/Gp to contain: Apixaban 5mq 30
Dabigatran Tab/Cap-
84 2080 Each p to contain: Dabigatran Etexilate 110 mg 30
Anticoagulants-
Each Kit to contain:Two Componant Fibrin Sealant With
85 2081 Sylthetic Aprotinin (4ml) 31
Terbutaline + Guiaphenesin + Ambroxol Syp-
Each 5 ml to contain: Terbutaline I.P 1.25m9 + Guiaphenesin
86 2203 I.P + Ambroxol I.P 15mg Syrup Base QS 31
Dextromethorphan + CPM Syp-
Each 5 ml to contain: Dextromethorphan I.P 10mg +
87 2204 Chlorpheniramine l4aleate I.P 2mg Syrup Base QS 37
Ibutilide-
Each ml to contain: Ibutilide Fumarate 0.1m9 ( Equivalent To
88 2205 Ibutilide Freebase 0.087m9), Water For injection 32
Glyceryl Trinitrate Spray-
89 2207 Each Metered Dose to contain: Glyceryl Trinitrate Spray -0.4 Mq ?1
Human Albumin-
Each Bott to contain- Human Albumin 25o/o 100 ml In Flexible,
90 2208 Self Collapsible- Closed System Baqs 33
Emicizumab Inj-
Each Vial Contains : Emicizumab 30mg For Sub Cut Injection (R-
91 2209 DNA Oriqin) 33
Emicizumab Inj-
Each Vial Contains : Emicizumab 60mg For Sub Cut Injection (R-
92 22l0 DNA Oriqin) 33
Page 5 of 8
Index 143C

No. no
Micronized - Purified Flavonoid Tab/Cap-
Each Film Coated Tab/Cap to contain : Micronized - Purified
Flavonoid Fraction 500m9 Composed Of Diosmin 450m9 (90%)
93 22tt And Flavonoids Expressed As Hesperidine 50mq (10o/o) J.i
Telmisartan Tab/Cap:
94 2299 Each Tab/Cap to contain: Telmisartan 20mg 34
Dabigatran Etexilate Tab/Cap-
95 2302 E.in"i.ulc"E" ilnt"nl OJuiqutran Etexitate lsomq 51
Acetyl Sdlicylic Acid + Atorvastatin Tqblcap-
q6
Each TdblGD to contaih: ACetyl Salicylic Acid 75m9,
2303 Atorvastatin 20mq 35
Diltiazem CR/ SR/ DR/ tvlR Tab/Gp-
97 2306 Each CR/ SR/ DR/ MR Tab/Cap to contain: Diltiazem 90mq 35
Codein Lint. Syp/Susp-
Each sml to contain: Chlorpheniramine Maleate 4mg, Codeine
98 2309 Phosphate 1omg 3s
Gabapentin+ Nortriptyline Tab/Cap-
Each Tab/Cap to contain: Gabapentin 100m9, No ftriptyline
99 2312 10mg 36
Prega balin Tab/Cap-
Each PLAIN/SR/CR/DR/ER/MR Tab/Cap to contain: Pregabalin
100 2377 75 36
Beclomethasone Inhaler-
Each Metered Dose to contain: Beclomethasone Dipropionate
101 1040b 100mcg. 36
Salbutamol Rotacap-
102 1043a Each Rotacap to contain : Salbutamol 200mcg
Metoprolol Tab/Cap-
103 1056a Each Tab/Gp to contain: 37
Iso-Sorbide Mononitrate Tab/ p-
104 1060a Each Tab/Cap to contain: Iso-Sorbide-S-Mononitrate 20 mg 37
Prazosin SR Tab/Cap-
105 1067b Each SR Tab/Gp to contain: Prazosin Hcl 2.5 mg 38
Prazosin SR Tabicap-
106 1067c Each SR Tab/Cap to contain: Prazosin Hcl 5mg 38
Ramipril Tab/ Cap-
\07 1068b Each Tab/ Cap to contain: Ramipril 2.smq 39
Ramipril Tab/Cap; '-
108 1068c Each Tab/Cap to contain: Ramipril smg 39
Phenobarbitone Tab/Gp-
109 1115b Each Tab/Cap to contain: Phenobarbitone-30m9 40
Carbamazepin CR Tab/Cap-
110 1727 a Each CR Tab/Cap to contain: Carbamazepin 200m9 40
Torsemide Tab/Cap-
111 1370b Each Tab/Cap to contain: Torsemide 20mq 40
Page 5 of I
Index 143C

No. no
Mirtazapine Tab/Cap-
tt7 1430b Each Tab/Cap to contaln: Mirtazapine 15mg 47
Clobazam Tab/Cap-
113 324a Each Tab/Cap to contain: Clobazam 5 mg 47
Clobazam Tab/Cap-
t14 324b Each Tab/Cap to contain: Clobazam LP.10 mq 41
Each ml to contain: Salbutamol Sulphate Eqv. to Salbutam ol 5

115 32b mg. In Normal Saline Soln. 42
Grvedilol Tab/Cap-
116 336b Each Tab/Cap to contain: Carvedilol 6.25m9 42
Enoxaprin Inj-
117 366a Each PFS to contain Enoxaprin Sodium 20 mg / 0.2 ml. 42
Enoxaparin 60 mg/0.6m1 Inj-
118 366c Each PFS to contain: Enoxaparin 60 mg/0.6m1 43
Fluticasone + Salmeterol Inhaler-
Each Metered Dose to contain: Salmeterol 25mcg, Fluticasone
119 420a 50mcg 43
Nicorandil TablCap-
t20 423a Each Tab/Cap to contain: Nicorandil 5mg 43
Sodium Valproate + Valproic Acid CR Tab/Cap-
Each CR Tab/Cap to contaln: (Sodium Valproate + Valproic Acid)
72t 433b Eqv. to Sodium aEl 500mq. 44
Propranolol Tab,/ Ca p-
722 44b Each conta in: Propranolol 40mg 44
Perindopril Tab/Cap-
tz3 470a Each Tab/Cap to contain: Perindopril 2mq 44
Perindopril Tab/Cap-
t74 470c Each Tab/Cap to contain: Perindopril Erbumine 8mg 45
Resperidone Tab/cap-
125 473a Each Tab/Cap to contain: Resperidone 1mq 45
Olanzapine Tab/Cap-
726 474b Each Tab/Cap to contain: Olanzapine 5mg 45
Haloperidol Tab/Cap-
727 475b Each Tab/Cap to contain: Haloperidol 5mg 46
Amitriptyline Tab/Gp-
128 477 a Each Tab/Cap to contain: Amitriptyline 10mg 46
Amitriptyllne Tab/Cap.
LZg 477b Each Tab/Cap to contain: Amitriptyline 25mq 46
Paroxetine Tab/Gp-
130 486a Each Tab/Cap to contaln: Paroxetine 1Omg 46
Paroxetine Tab/Cap-
131 486b Each Tab/Cap to contain: Paroxetine 20mg 47
I4etoprolol ER Tab/Gp-
Each ER Tab/Cap to contain: Metoprolol Succinate 47.5m9
132 525a Equivalent to Metoprolol Tartrate 50mq. 47
Gabapentin Tab/Cap-
133 527a Each Tab/Cap to contain: Gabapentin 300m9 48
Page 7 of 8
r-
Index 143C

No. no
Clozapine Tab/Cap-
734 555a Each Tab/Cap to contain : Clozapine 25mg 48
Clozapine Tab/Cap-
135 555b Each Tab/Gp to contain: Cl ozapine 100m9 48
Escitalopram Tab/cap-
136 556a Each Tab/Gp to contain: Escitalopram 10 mq 49
737 556b : Escitalopram 20 mq 49

Dalteparin Sodium Inj-
138 557a Each PFS to contain: Dalteparin Sodium 2500 IU Units 49
Dalteparin Sodium Inj-
139 557b Each PFS to n 5000 IU Units 50
Ethamsylate Tab/Crp-
140 68a Each Tab/Cap to contain Ethamsylate 250 mq 50
Streptokinase Inj-
141 74a Each Vial to contain: Streptokinase I.P 7.5 Lac IU 50
Page I of 8
Employes' StaE fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12lf42C-L46C|zOLg-Med V FOR RC 143C
Valid from Thursdan October 14U, 2O2L to Tuesday, October 315t 2023
ftem No Drug Description Packing
Firm Name Firm Rate/ Preference De*ription of stores ac@pted

unit Packing
33 Bronchodilator Syp- 200m1 Bottle

Each 5ml to contain:
Theopyllin Ethanoate Of Piperazine 80m9,
Eph. Hcl.12mg, Guaiphenesin 50m9,
Alcohol 0.55mlt'Absolute Alcohol Contqn!.!q419lo.:
Hindustan 47.24 200 ml FIRST HIPH E R
Laboratories 200m1 Bott Bottle., SAME AS I ITEM
Limited
Rupees Forty seven AND Paise Two Four Only
60 Frusemide Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Frusemide 40mg
Micron 0.36 Per 10 Tabs

Pharmaceuticals l Tab/Cap
Rupees Nil AND Paise Three Six Only
63 Isoxsuprine Inj- 2ml Vial/Amp

Each ml to contain: Isoxsuprine smg
Juggat Pharma 9.00 Per 2ml Amp FIRST TIDITAN

(Pharma Division 2ml ViaUAmp IN ITEM
Of Jagdale
lndustries Private
Limited)
Rupees Nine Only
77 Heparin Sodium Inj- 5ml Vial/Amp

Each ml to contain: Heparin Sod.5000 IU
Sai Parenterals Pvt. 195.O0 Per l Vial FIRST SAME AS IN ITEM

Ltd. sml ViaUAmp
Rupees One Hundred Ninety Five Only

J_.^--*
/-
Page 1 of 50
Em ptoy@s' State fnsuran@ Corporation
V FOR RC 143C
Rate Schedule of Running Rate contract No. U-25/121142C-L46C12OL9-Med
Valid from Thursday, October 14th 2021 to Tuesday, October 31"t 2023
ftem No Druo
Firm Name Firm Rate,/ Firm Preference De*ription of storcs acepted

unit Packino
Flunarizine Tab/CaP- 1 Tab/Cap

75
Each Tab/Cap to conta in: Flunarizine 10mq
FDC Limited 0.39 Per 10Tabs FIRST FLUNARIN 10 MG
l Tab/Cap SAME AS IN ITEM
t
Rupees Nit AND Paise Three Nine Only
97 Fluoxetine Tab/CaP- 1 Tab/Cap

Each Tab/Cap to contain: Fluoxetine 20mg
Hab 0.58 Per 10 TabS FIRST ELEVAT
Pharmaceuticals & l Tab/Cap SAME AS Iil ITEM
Research Ltd
Rupe Nil AND Paise FiYe Eight OnlYo
Mesmer 1.50 Per 10 Tabs SECOND FLOATIN 20 MG
Pharmaceuticals l Tab/Cap SAME AS IN ITEt"l
Rupees One AND Paise Six Zeru OnlY
98 Phenytoin Sodium Tab/CaP- l Tab/Cap

Each Tab/Cap to contain: Phenytoin Sodium 100m9
Revat Laboratories o.30 Per 10 Tabs FIRST SAME AS IN ITEM

Pvt. Ltd. l Tab/Cap
Rupe Nil AND Paise Thre Zerc OnlY
Zydus Healthcare 0.36 Per looTabs SECOND EPSOUN

Ltd l Tab/Cap SAME AS IN ITEM
Rupees Nil AND PaiseThre Six OnlY
Abbott India 0.41 Per 120 Tabs THIRD EPTOIN

Limited l Tab/Cap SAME AS IN ITEM
Rupees Nil AND Paise Four One Onl2
Page 2 of 50 t.
Em ployees' State fnsura nce Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|2OL9-Med V FOR RC 143C
Vafid from Thursday, October L4tj 2O2L to Tuesday, October 31't 2023
Firm Name Firm RaE/ Prefercnce Dexription of stores acepted

unit Packing
103 Trihexyphenidyl Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain:
Trihexyphenidyl Hydrochloride 2mg
Micron O.72Per 10 Tabs FIRST SAME AS IN ITEM
Pharmaceuticals 1 Tab/Cap
Rupees Nil AND Paise Seven Two Only
362 Budesonide Inhaler- Equal to or more than 120 MDI

Each Metered Dose to contain :
Budesonide 100 mcg

Cipla Limated 0.35 Per 2OO MDT FIRST BUDECORT 1OO CFC FREE INH
dose (WITH DOSE COUNTER)
SAME AS IN ITEM
Ru6es Nil AIVD Paise Thrce Five Only

Midas Care Per
0.36 240 MDI SECOND BUDESONE 1OO INHATATION
Pharmaceuticals dOse SAMEASIN ITEM
Pvt. Ltd.
Rupees Nil AND Paise Three Six Only
365 Losartan+Hydrochlorthiazide Tab/Cap- 1 Tab/Cap
Losartan Potassium 50 mg,
Hydrochlorthiazide 12.5 mq
Hab 0.84 Per l0Tabs FIRST LOSARK-H
Pharmaceuticals & l Tab/Cap SAME AS IN ITEM
Research Ltd
Rupees Nil AllD Paise Eight Four Only
Macleods 1.07 Per 15 Tabs SECOND OMNTTAN H

Pharmac€uticals l Tab/Cap SAME AS IN ITEM
Limited
/1*
Rupees One AND Paise Zero Seven Only
u
Page 3 of 50
Employees' State fnsurance Corporation
Rate Schedute of Running Rate Contract No. U-25/12l142C-l46Cl20l9-Med V FOR RC 143C
Valid from Thursday, October 1#h 2021 to Tuesday, october 31't 2023
ftum No Drug Description Packinq
Firm Name Firm Rate/ Preference De*ription of s'tores ac@pbd

unit Packing
367 Fenofibrate TabiCap- 1 Tab/Cap

Each Tab/Cap to contaln:
Fenofibrate ( Micronised ) 200 mg
Micron 1.80 Per 10 Tabs FIRST SAME AS IN ITEM
Rupees One AND Paise Eight Zero Only
USV Private Limited 2.68 Per Strips of SECOND UPICARD 20OMG

l Tab/Cap 10 Caps SAME AS IN ITEM
Rupees Two AND Paise Six Eight Only
42t Ipratropium + Salbutamol Inhaler- Equal to or more than 120 MDI

Each Metered Dose to contain:
Ipratropium I.P.20mcg., Salbutamol I.P.100mcg
Midas Care 0.90 Per 240 MDI FIRST SAUPRAIR HFA INHALATION
Pharmaceuticals dose SAME AS IN ITEM
Pvt. Ltd.
Rupees Nil AND Paise Nine Zero Only
422 Amiodarone Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Amiodarone Hcl 100m9
Signature 2.40 Per 10 Tabs FIRST SAME AS IN ITEM

Phytochemical l Tab/Cap
lndustries
Rupees Two AND Paise Four Zeru Onlln
Page 4 of 50
Em ployees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|zOL9-Med V FOR RC 143C
Valid from Thursday, October L4th 2O2L to Tuesday, October 31"t 2023
Firm Name Firm Rate/ Prefercnce Description of storcs ac@pted

unit Packing
425 Indapamide SR Tab/Cap- 1 Tab/Cap

Each SR Tab/Cap to contain : Indapamide 1.5 mg
Modi Mundipharma 2.5O Per 10 Tabs FIRST INDICONTIN
Private Limited I Tab/Cap SAME AS IN ITEM
Ruryes lwo AND Paise Five Zeto Only
Serdia 5.90 Per 10 Tabs SECOND NATRILIX SR

Pharmaceuticals l Tab/Cap SAME AS tN ITEM
(tndia) Private
Limited
Rupees Five AND Paise Nine Zeto Only
429 Clopidogrel Tab/Cap- 1 Tab/Cap

Eac h Tab/Cap to contain: Clopidogrel 75mq
Pulse O.72Per 10 Tabs FIRST CTOTREL 75
Pharmaceutical Art l Tab/Cap SAME AS IN ITEM
Ltd
Rupees Nil AND Paise Seven Two Only
lark Laboratories 0.78 Per 10 Tabs SECOilD CLOPILAR
(India) Ltd. l Tab/Cap SAME AS IN ITEM
Rupees Nil AND Paise Seven Eight Only

Themis Medicare 0.82 Per 10 Tabs THIRD THEMIGRET
Rupees Nil AND Paise Eight TWo Only

47t Tianeptine Tab/Cap- l Tab/Cap
lianeptine Sodium 12.5m9
Serdia 4.77 Per 10 Tabs FIRST STABLON
Pharmaceuticals l Tab/Cap SAME AS IN ITEM
(India) Private
Limited
Ru$es Four AND Paise Seven *ven Only
Page 5 of 50
f*',*
Employes' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/121142C-t46Clz0l9-Med V FOR RC 143C
Valid from Thursdan October l4th 2O2L to Tuesday, October 31.t 2023
ftum No Drug Description Packing
Firm Name Firm Rate/ Firm Prefercnce Dexription of stores ac@phd

unit Packing
481 Ipratropium Resp. Soln- 15ml Eottle

Each ml to contain:Ipratropium Bromide 250 mcg
Cipla Limated 14.90 Per 15ml FIRST IPRAVENT RESPIRATOR SOI.

15ml Bott Bottle SAME AS IN ITEM
RuBes Fouften AND Paise Nine Zeru Only
516 Etophylline & Theophylline Syp- 100m1 Bottle

Each 5 ml to contain:
Etophylline 46.5m9. , Theophylline 14mg
Micron 14.40 Per 100m1 FIRST DUOLLIN

Pharmac€uticals 100m1 Bott Bottle SAME AS IN ITEM
Rupes Fourten AND Paise Four Zero Only
518 Cough Sedative Syp- 100m1 Bottle

Chlorphen iramine Meleate 2.5m9,
Guaiphenesin 100m9, Noscapine 15m9,
Sodium Citrate 60 mg.
Hindustan 33.74 Per 100m1 FIRST HIMALEATE

Laboratories 100m1 Bott Bottle SAME AS IN TTEM
Limited
Thifi Thre AM
f"ry
Rupees Paise Seven Four Only
Page 6 of 50
Rate Schedule of Running Rate Contract No. U-251 L2l142C-t46ClzOL9-Med V FOR RC 143C
Valid from Thursday, October L4$ 2O2L to Tuesday, October 31't 2023
Firm Name Firm Rate/ Preference Description of sbres ac@pted

unit Packing
52r Tranexamic Acid Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Tranexamic Acid 500m9
Psychotropics India 4.65 Per 1O Tabs FIRST GYNAEPIL 5OO

Rupees Four AND Paise Six Five Only
Macleods 6.33 Per 6Tabs SECOND TRENAXAS00

Pharmaceuticals l Tab/cap SAMEAS IN ITEM
Limited
Rupees Six AND Pai* Thrce Thr* Only

FDC Limited 7.50 Per 10 Tabs THIRD CLIP 500
l Tab/Cap SAME AS rN ITEM
Ru@es Seven /lND Paise Five Zerc Only
522 Tranexamic Acid Inj- 1 Amp

Each 5ml to contain: Tranexamic Acid 500m9
Psychotropi6 India 12.60 Per l Amp FIRST GYNAEPIL

Limit€d l Amp SAME AS IT{ ITEM
Rupees Twelve AllD Pai* Six Zeto Only
540 Sulbutiamine Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Sulbutiamine 200m9
Serdia 12.07 Per 10 Tabs FIRST AR,CALION

Pharmaceuticals I Tab/Cap SAME AS IN ITEM
(India) Private
Limited
Rupees Tweltle AND Pai* Zeto
Page 7 of 50
*ven Only,
*<
Employees' State Insu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25/121142C-l46Cl20l9-Med V FOR RC 143C
Valid from Thurcday, October L4th 2O2L to Tuesday, October 315t 2023
f@m No Drug Description Packing
Firm Name Firm Rate/ Prefercnce Dexription of stores accepted

unit Packing
550 Fluticasone+Salmetrol Rotacap- l Rotacap

Each Rotacap to contain: Fluticasone 250 mcg,
Salmetrol 50 mcg
Cipla Limited 1.02 Per 30 Caps FIRST SEROFLO 250 ROTACAPS
1 Rotacap Bottle SAlrlE AS IN ITEM
Rupees One AND Paie Zero Two Only

Zydus Healthcare L.l7 Per 30 Caps SECOND FORAIR 250 RESPICAP
Ltd 1 Rotacap Bottle SAME AS IN ITEM
Rupees One AND Paie One *ven Only

Macleods 1.23 Per 30 Caps THIRD FIUTROL 2S0
Pharmaceuticals 1 Rotacap Bottle (HARD GE|-ATIN CAPSULE)
Limited SAME AS IN ITEM
Rupe* One AND Pai* Two Thrce Only

574 Metoprolol Ini 5ml Vial/Amp
Each ml to contain: Metoprolol lmg
Cipla Limited 12.00 Per 5ml Vial/ FIRST METOLAR
Sml Vial/Amp Amp SAME AS IN ITEM
R Twelve
sB0 Coagulant Solution- 10ml Bottle
Each ml to contain: Aqueous Solution Of
Haemocoagulase Isolated From Bothrops Atrox Or
Bothrops Jararaca 0.2CU, Chlorhexadine Gluconate
Soln.0.lpercent (As Preservative), Water For
Injection Q.S.
Juggat Pharma 75.50 Per 10ml FIRST BOTROCTOT TOPICAL
(Pharma Division 10ml Bott Bottle SOLUTION
Of Jagdale SAME AS IN ITEM
Industries Private
Limited)
Rupes *venty Six AND Pai* Five Zeru Only 7
iz o<l-*a-,>l*r.+
/.-
Page 8 of 50
Em ployees' State fnsura nce Corporation
Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|zotg-Med V FOR RC 143C
Valid from Thursday, October L4tn 2O2L to Tuesday, October 313t 2023
Firm Name Firm Rate/ Preference De*ription of stores ac@phd

unit Packing
1032 Etophylline & Theophylline TabiCap- 1 Tab/Cap

Etophylline 77 mg,Theophylline 23 mg
Micron O.27 Per 10 Tabs FIRST SAME AS IN ITEM
Pharmac€uticals l Tab/Cap
Rupees Nil AND Paise Two Seven Only

Zydus Healthcare 0.33 Per 30 Tabs SECOND DERIPHYLLIN
Ltd l Tab/Cap SAMEAS IN ITEM
Rupees llil AND Paise Three fhrce Only
1041 Salbutamol + Beclomethasone Inhaler- Equal to or more than 120 MDI

Salbutamol 100 mcA.,
Beclomethasone Dipropionate 50 mcq.
Midas Care 0.45 Per 240 MDI FTRST SALBESONE INHALATION
Pvt. Ltd.
Rupees Nil AND Paise Four Slx Only

1050 Pediatric Cough Linctus Syp - 50ml Bottle
Each ml to contain : Noscapine 1.83m9,
Citric Acid 5.8m9, Sod. Citrate 0.67m9,
Amm. Chloride 7mg
Hindustan 23.21 Per 50ml FIRST HISCOPINE PAEDIATRIC
Laboratories 50ml Bott Bottle SAME AS IN ITEM
Limited
Rupees fwenty Thtce AND Paise Tluo One Only

?
W
Page 9 of 50
Employes' Sbte fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OL9-Med V FOR RC 143C
Valid from Thursday, October 14d' 2021 to Tuesday, October 31't 2023
Firm Name Firm Rate/ Firm Preference Dexription of stores ac@pted

unit Packing
1055 Bisoprolol Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Bisoprolol Fumerate 5 mg
Intas 1.67 Per 10 Tabs FIRST BISELECT-5

Pharmaceuticals l Tab/Cap SAME AS IN TTEM
Ltd
Rapes One AND Pai* Six Seven Only
1063 Trimetazidine Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Trimetazidine Hcl 20 mq
Themis Medicare 0.52 Per 10 Tabs
FIRST THEMIDON
Rupees Nil AND Paise Five tuw Only

Serdia 6.43Per lOTabs SECOND FTAVEDON 20
Pharmaceuticals l Tab/Cap SAMEAS IN ITEM
(India) Private
Limited
Rupees Six AND Paise Four Thrce Only
1074 Isoxsuprine Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Isoxsuprine Hcl 10 mg
Overseas 0.54 Per 10 Tabs FIRST PREGNIN
Healthcarc Art Ltd l Tab/Cap SAME AS IN ITEM
Rupes llil AND Paise Five Four Only
1078 Haemo-Coagulant Inj- 1ml Vial/ Amp

Each ml to contain : Aqueous Solution Of
Haemocoagulase (One I U/CU/NIH Unit) Isolated
From Venom Of Bothrops, Jararaca Or Bothrops
Atrox Containing Sodium Chloride 0.9olo
Juggat Pharma 71.15 Per 1ml ViaU FIRST BOTROPASE INJECTION
(Pharma Division lm! ViaU Amp SAME AS IN ITEM
Of Jagdale Amp
Industries Private
frr
Limited)
Rupees *venty One AND Paise One Fiye Only
//
Page 10 of 50
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OLg-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023
fEm No Drug Desciption Packing
Firm Name Firm Rate/ Preference Dexiption of stores acepfud

unit Packing
tt24 Nimodipine Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Nimodipine 30 mg
USV Private Limited 3.25 Per 10 Tabs FIRST NIMODIP

Rupees Thrce AND Paise Two Five Only
1131 Sodium Valproate Tab/Cap - I Tab/Cap

Each Tab/Cap to contain: Sodium Valproate 200m9.
Hab 0.80 Per 10 Tabs FIRST EPIVALPRATE-2OO

Pharmaceutacals & l Tab/Cap (ENTERIC COATED TABLET)
Research Ltd SAME AS IN ITEM
Rupees Nil AND Paise Eight Zero Only

Psychotropics India 0.86 Per 10 Tabs SECOND TAB VALATE 2OO
Limited l Tab/Cap (ENTERIC COATED GASTRO
RESISTANT TABLET)
SAME AS IN TTEM
Rupees Nil AND Paise Eight Six Only

Sanofi - Synthelabo 2.47 Pq 10 Tabs THIRD VALPARIN ALKALTES 2OO
(India) Pravate l Tab/Cap (EACH ENTERIC COATED
Limited GASTRO RESISTANT TABLFT)
SAME AS IN ITEM
Ru@es Two AND Paise Four *ven Only
Page 11 of 50
Employees' State Insura nce Corryration
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|2OL9-Med V FOR RC 143C
Valid from Thursday, October t4th 2O2l to Tuesday, October 31't 2023
Firm Name Firm Rate/ Prefercnce Description of stores accepted

unit Packing
1t32 Levodopa & Carbidopa Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Levodopa 250 mg,
Carbidopa 25 mg
Sun Pharma 2,80 Per 10 Tabs FIRST SAME AS IN ITEM
Laboratories I Tab/Cap
Limited
Rupees Two AND Paise Eight Ze,o Only
1348 Valsartan Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Valsartan B0mg
Lark Laboratories 1.98 Per 10 Tabs FIRST VALSALAR-80

(India) Ltd. l Tab/Cap SAME AS IN TTEM
Rupes One AND Paise Nine Eight Only
t349 Ivletolazone Tab/Cap- l Tab/Cap

Each Tab/Cap to contain Metolazone 5mg
Zydus Healthcare 6.30 Per 10 Tabs FIRST ZYTAND( 5

Ltd l Tab/Cap SAME AS IN TTEM
Rupees Six AND Paire Thrce Zerc Only

Centaur 8.11 Per 10 Tabs SECOND METOZ 5 MG
Prrt. Ltd.
Rupees Eight AND Paise One One Only
/"'Y
Page 12 of 50
Employees' State fnsu ra nce Corporation
Rate Schedule of Running Rate Contract No, U-25/12l142C-L46C|zOLg-Med V FOR RC 143C
Valid from Thursday, October 14rh 2O2L to Tuesday, October 31st 2023
fbm No Drug Description Packing
Firm Name Firm Rate/ Prefetence Description of storcs ac@phd

unit Packing
t370 Torsemide Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Torsemide 10mg
Cipla Limited 0.57 Per 15 Tabs FIRST DYTOR 10

l Tab/Cap SAME AS IN rTEM
Rupees Nil AND Paise Five Seven Only

Intas 1.65Per 15 Tabs SECOND TOR-10
Ltd
Rupees One AND Pai* Six Six Only
Centaur 1,89Per loTabs THIRD MELTOR 1OMG
Pharmaceuticals l Tab/Cap SAME AS IN rTEM
Pt t. Ltd.
Rupees One AND Paise Eight Nine Only
1372 Perindopril + Indapamide Tab/Cap- l TabiCap

Perindopril Erbumine 4mg, Indapamide 1.25m9
Serdia 7.7O Per 10 Tabs FIRST COVERSYT PLUS
(India) Private
Limited
Rupees Seven AND Paise Seven Zerc Only
1393 l'lefenamic + Tranexamic Acid Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Mefenamic Acid 250m9,
Tranexamic Acid 500m9
Hab 4.90 Per 10 Tabs FIRST CYCKLATRAN-M
Research Ltd
Rupees Four AND Paise Nine Zero Only
Macleods 7.L7Per 6Tabs SECOND TRENAXAMF

Limited
Rupees Seven AND Paise One Seven Only
Page 13 of 50
/^y
Employees' Sbte fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-146C12019-Med V FOR RC 143C
Firm Name Firm Rate/ Preference De*rtption of storcs ac@phd

unit Packing
1420 Telmisartan Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Telmisartan 40mg
Pulse 0.57 Per 15 Tabs FIRST TELDIL 40

Pharmaceutical Pt t l Tab/Cap SAME AS IN ITEM
Ltd
Rupees Nil AND Paise Five Seven Only

Psychotropics India 0.69 Per 10 Tabs SECOND TELPIT 40
Rupees Nil AND Pai* Six Nine Only

Troikaa 0.95 Per 10 Tabs THIRD TELMIKAA 40
Pharmaceuticals l Tab/Cap SAI.{E AS IN ITEM
Limited
Rupees Nil AND Paise Nine Five Only

t42r Perindopril + Amlodipine Tab/Cap- l Tab/Cap
Each Tab/Cap to contain: Perindropil 4mg,
Amlodipine 5mg
Serdia 6.45 Per lOTabs FIRST covERsYL - AM 415
(India) Private
Limited
Rupees Six AND Pai* Four Five Only
1461 Hydroxyzine Hydrochloride Tab/Cap- 1 Tab/Cap

Hydroxyzine Hydrochloride 25mg
Psychotropics India 0.79 Per 10 Tabs FIRST HYDIL 25
Rupees Nil AND Paise Seven Nine Only

{*
Page 14 of 50
Em ployees' State fnsu ra nce Corporation
Rate Schedule of Running Rate Contract No.U-25lL2lL42C-l46Clz0l9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023
Firm Name Firm Rate/ Firm Prefercnce De*ription of stores accepfud

unit Packing
t522 Inhaler - Equal to or more than 120 N4DI

Ipratropium 20mca,
Levosalbutamol 50mcg
Midas Care 0.45 Per 24O MDI FIRST SALIPRAIR L 20 HFA
Pharmaceuticals dose INHALATION
Art. Ltd. SAME AS IN ITEM
Rupees Nil AND Paise Four Five Only

Cipla Limited 0.45 Per 200 MDI FIRST DUOLIN CFC FREE INH
SAME AS IN ITEM
Ruryes Nil AND Paise Four Five Only
L524 Budesonide Respule- 2ml Amp

Each 2ml to contain :
Budesonide 1mg Steriod Nebulizing Fluid
Cipla Limited 5.88 Per 2ml FIRST BUDECORT lMG

2ml Amp Respule SAME AS IN ITEM
Rupees Five AND Paise Eight Eight Only4
Page 15 of 50
l"Y
Employees' State Insura nce Corporation
Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|2OL9-Med V FOR RC 143C
Valid from Thursday, october 14th 2021 to Tuesday, October 31't 2023
Firm Name Firm Rate/ Preference Description of stores acepted

unit Packing
1525 Tlotropium Bromide Rotacap- l Rotacap

Each Rotacap to contain : llotropium Bromide IP/BP
Eqv. to Tiotropium Bromide Monohydrate 18mcg.
Cipla Limited 1.29 Per 30 Caps FIRST TIOVA ROTACAPS
1 Rotacap Bottle SAME AS IN ITEM
Rupees One AND Pai* Two Nine Only
Zydus Healthcare 1.39 Per 15 Caps SECOND TIOMIST RESPICAPS

Ltd 1 Rotacap Bottle SAME AS IN ITEM
Rupees One AND Paise fhrce Nine Only
Macleods 2,27 Per 15 Caps THIRD AEROTROP

Pharmaceuticals 1 Rotacap Bottle (HARD GELAIN CAPSULE)
Rupees Two AND Paise Two Seven Only
1530 Ivabradine Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Ivabradine 5mg
Macleods 4.03 Per 10 Tabs FIRST IVAMAC 5

Limited
Rupees Four AND Paise Zero Thrce Only
Serdia Per
15.00 14 tabs SECOND CORAI-AN sMG
Pharmaceuticals l Tab/Cap Manufactured by:-
(India) Private Les Laboratoires Servier
Limited Industrie, France
SAME AS tN ITEM
Ru@es Fifteen Only
t:
Page 16 of 50
Rate Schedule of Running Rate Contract No. U-251121142C-L46C|zOL9-Med V FOR RC 143C
Valid from Thursday, October L4rb 2O2l to Tuesday, October 31i 2023
Firm Name Firm Rate/ Prefercnce De*ription of stores ac@pted

unit Packing
1668 Olmesartan Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain : Olmesartan 20mg
Psychotropics India 0.82 Per 10 Tabs FIRST OLIPIL 20

Rupees l{il AND Paise Eight Two Only
Zydus Healthcare 1.33 Per 10 Tabs SECOND OIMY 20

Ltd l Tab/Cap SAMEAS IN ITEM
Rupees One AND Pai* Thrce Three Only
Macleods 3.00 Per 15 Tabs THIRD OTMESAR 20

Limited
Rupees Thte Only
t670 Haemostatic- 5ml

Haemostatic Matrix With Prefilled Gelatin Granules
In Syringes
Baxter (India) Pvt 13125.00 Per Sml InJ.
FIRST FLOSEAT sML
Ltd 5ml Manufactured By:-
Baxter Healthcare
Corporation, 21026
Alexander court Hayward
California US 94545
SAME AS IN ITEM
Ruwes Thifteen Thoumnd One Hundrcd Twenty Five OnlP
7^*
t:
PaBe 17 of 50
Employees' Sbte Insuran@ Corporation
Rate Schedule of Running Rate Contract No, U-25/12l142C-1,46C12OL9-Med V FOR RC 143C
Valid from Thursday, October L4th 2021. to Tuesday, October 31st 2023
Firm Name Firm Rate/ Ptefetence Oexriefion of sbrcs acepEd

unit Packing I I
t674 Sumatriptan Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Sumatriptan 50mg
Sun Pharma 33.00 Per 10 Tabs FIRST SAME AS IN ITEM
Laboratories I Tab/Cap
Limited
Rupees Thirty Three Only
1681 Citicoline Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Citicoline 500 mg
Pulse 9.12 Per 10 Tabs FIRST COLIBRA

Pharmaceutical hrt l Tab/Cap SAME AS IN ITEM
ttd
Rupees Nine AND Paise One Two Only
Bajaj Healthcare LO,77 Per 10 Tabs SECOND SAME AS IN ITEM

Limited l Tab/Cap
Rupees Ten AND Paise Seven Seven Only
USV Private Limited 2O.O0 Per 10 Tabs THIRD CITINERVE

Rupees Twenty OrtfA
Page 18 of 50
4r-^-,r-,r r'-
/.
Employes' StaE Insurance Corporation
Rate Schedule of Running Rate Contract No.U-25lLzlL42C-l46Clz0lg-Med v FOR RC 143C
Valid from Thursday, October L4rh aOZL to Tuesday, October 3L* 2023
Firm Name Firm Rate/ Firm Preference Description of sfurcs acepted

unit Packing
1682 Divalproex Sod. Tab/Cap- 1 Tab/Cap

Each SR/ER/CR Tab/Cap to contain:
Divalproex Sod. 250m9
Pulse 1,71 Per l0 Tabs FIRST DIOVAT XR 250
Pharmaceutical Pvt 1 Tab/Cap SAME AS IN ITEM
Ltd
Rupees One AND Pai* Seven One Only
Zydus Healthcare 1.80Per 10 Tabs SECOND DMTPRO XR 250

Rupees One A^lD Pai* Eight Zero Only
Intas 4.48Per lOTabs THIRD DIVAA-OD 250

Ltd
Rupees Four AND Paise Four Eight Only
1683 Divalproex Sod. Tab/Cap- 1 Tab/Cap

Each SR/ER/CR Tab/Cap to contain:
Divalproex Sod. 500m9
Pulse 2.53 Per 10 Tabs FIRST DIOVATXR 5OO
Ltd
Rupees Two AND Paise Five Thre Only

Intas 6.90Per 10 Tabs SECOND DMA-OD 5OO
Pharmaceuticals I Tab/Cap SAME AS It{ ITEM
ttd
Rupees Six AND Paise Nine Zero Only
/-^:
Page 19 of 50
Employees' State fnsura nce Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C'L46C|2OLg-Med V FOR RC l43C
Valid from Thursday, October L4th 2O2l to Tuesday, October 31st 2023
Firm Ndme Firm Rate/ Preference De*ription of storcs acephd

unit Packing
t749 Inhaler- Equal to or more than 120 MDI

Levosalbutamol Tartrate 50mcg
Midas Care O.27 Per 240 MDI FIRST BONAIR L HFA INHALATION
Pvt. Ltd.
Rupees Nil AND Paise Two Seven Only

Cipla Limited 0.33 Pe r 2OO MDI SECOND LEVOTIN CFC FREE INH
dose (Wml DosE couNTER)
SAME AS IN ITEM
Rupees Nil AND Paise Three Thrce Only
175t Nebivolol Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Nebivolol Smg
Macleods 1,80 Per 10 Tabs FIRST NEBIMAC 5 MG

Limited
Rupees One AND Paise Eight Ze,o Only
t752 Tenecteplase 40mg Inj- 1 Vial

Each Vial to contain: Tenecteplase 40mg
Gennova 22990.00 Per l Vial FIRST ELAXIM /+O
Biopharmaceuticals l Vial SAME AS IN ITEM

Ltd.
Rupees TwentyTwo Thouand Nine Hundrcd Ninev Only

4"-,r*
/_
Page 20 of 50
Employes' Sbte fnsuran@ Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46Cl2Ol9-Med v FOR RC 143C
Valid from Thursday, October L4th 2O2L to Tuesday, October 31"t 2023
Firm Name Firm Rate/ Preference Description of stores accepted

unit Packing
1754 Indapamide SR + Amlodipine Tab/Cap- 1 Tab/Cap

Tab/Cap Indapamide SR 1.5 mg,
Amlodipine Besylate Equivalent To Amlodipine 5 mg
Serdia 7.79 Per 10 Tabs FIRST NATRILAM 5
(India) Private
Limited
Rupees Seven AND Paise Seven Nine Only
1840 Inhaler- Equal to or more than 120 MDI

Each Delivered Dose to contain: with/ without spacer
Salmetrol Xinafoate IP Equivalent to Salmetrol IP
25 pg, Fluticasone Propionate IP 250p9, Excipients
& Propellant 1, 1,1, 2 Tetrafluoro Ethane HFA 134a
Midas Care 0.53 Per 240 MDI FIRST FLUSAL 250 HFA INHALATION
Pvt. Ltd.
Rupees Nil AND Paise Six Three Only
Cipla Limited 0.86 Per 120 MDI SECOND SEROFTO 250 CFC FREE INH
dose SAME AS TN ITEM
Rupees Nil AND Paise Eight Six Only
1843 Autohaler- Equal to or more than 120 MDI

Each Delivered Dose Of Autohaler to
contain:
Salmeterol (As Salmeterol Xinafoate) IP 25 mcg,
Fluticasone Propionate IP 250mcg Suspended In
Propellant 134a Q.S. (Contalns Absolute Alcohol Ip
5o/o v lv)
Cipla Limited 3.25 Per 2OO MDI FIRST SEROFTO 250 AUTOHALER
dose SAME AS IN ITEM
Rupees Three AND Paise Two Five Only
Page 21 of 50
l'^:
Rate Schedule of Running Rate Contract No. U-251121142C-L46C|2OL9-Med V FOR RC 143C
Firm Name Firm Rate/ Preference Description of stores accepfud

unit Packing
1845 Metoprolol Succinate SR Tab/Cap- 1 Tab/Cap

Each SR Tab/Cap to contain:
I4etoprolol Succinate 23.75m9 Equivalent To
It4etoprolol Tartrate 25mg
Pulse O.47 Per .10rabs FIRsr l_"tl9gE!-2!_: .^_-
Pharmaceutical hrt l Tab/Cap (uNCoATED PROLONGED
Ltd RELEASE TABLEI)
SAME AS IN TTEM
Rupees Nil AND Paise Four Seven Only

Cipla Limited 0,52 Per 15 Caps METOLAR XR 25 CAP
l Tab/Cap (HARD GELANN EXTENDED-
RELEASE CAPSULE)
SAME AS IN ITEM
Rupees Nil AND Paise Five Two Only

Macteods 2.7O Per 10 Tabs THIRD METOMAC 25
Pharmaceutacals l Tab/Cap (EffENDED -RELEASE TABLEI)
Rupees Two AND Paise Seven Zero Only
1869 Amisulpride Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Amisulpride 50mg
Mesmer 1.59 Per 10 Tabs FI E50MG

Rupees One AND Paise Six Nine Only

-r-
4,-/"'1il-
Page 22 of 50
t-
Employees' State Insu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|2OL9-Med V FOR RC 143C
Firm Name Firm Rate/ Preference Description of stores accepfud

unit Packing
1870 Quetiapine Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Quetiapine 25 mg
Mesmer 0.94 Per 10 Tabs FIRST QUSER 25

Rupees Nil AND Paise lline Four Only

Intas 1.99 Per 10 Tabs SECOND QUTAN-2S
Pharmaceuticals l Tab/cap SAME As IN ITEM
ttd
Rupes One AND Pai* Nine Nine Only
L87t Quetiapine Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Quetiapine 100 mg
Mesmer 1.51 Per loTabs FIRST QUSER 100

Rupees One AND Paise Five One Only
Intas 3.94Per 10 Tabs SECOND QUTAN-100

Ltd
Rupees mre AllD Paise Nine Four Only
1873 Paroxetine CR Tab/Cap- l Tab/Cap

Each CR Tab/Cap to contain: Paroxetine 25mg
Intas 12.91 Per 10 Tabs FIRST PEXEP-CR-25

Ltd
Rupees Twelve AND Paise Nine One Onlyo
/**:
Page 23 of 50
Rate Schedule of Running Rate Contract No, U-25/12l142C-L46C|zOLg-Med V FOR RC 143C
Valid from Thursday, October L4rh 2O2! to Tuesday, October 31't 2023
frcm No Drug Description Packing
Firm Name Firm Rate/ Firm Prefetence De$ription of stores acepted

unit Packing
t879 Levetiracetam Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Levetiracetam 500m9
Pulse 2.42Per IO Tabs FIRST EPINEXT 5OO
Pharmaceutical Pvt l Tab/Cap SAME AS IN ITEM
Ltd
Ruwes TWo AND Paise Four Two Only
Hab 2.90 Per 10 Tabs SECOND SAME AS IN ITEM

Pharmaceuticals & l Tab/Cap
Research Ltd
Rupees Two AND Paise Nine Zeru Only
Cipla Limited 2,92Per 15 Tabs THIRD LEVEPSY 5OO SAME AS IN

l Tab/Cap ITEM
Rupes TWo AND Paise Nine TWo Only
1880 Levetiracetam Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Levetiracetam 250mq
Pulse 1,49 Per 10 Tabs FIRST Epinext 250
ttd
Rupees One AND Pai* Four Nine Only
Cipla Limited 1.54 Per 15 Tabs SECOND LEVEPSY 250

Rupees One AND Pai* Five Four Only
Zydus Healthcare 1.80 Per 60 Tabs THIRD LEVEI 500 MG

ttd l Tab/Cap SAME AS IN ITEM
Rupees One AND Paise Eight Zero Only4)
Page 24 of 50 /**
Employees' Sbte f nsu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-t46ClzOL9-Med V FOR RC 143C
Firm Name Firm Rate/ Preference Description of stores ac@pted

unit Packing
1883 Lamotrigine Tab/Cap- l Tab/Gp

Each Tab/Cap to contain: Lamotrigine 100m9
Intas 6.18 Per 10 Tabs FIRST LAMEZ-1OO

Ltd
Rupees Six AND Paise One Eight Only
2014 Montelukast Sodium Tab/Cap- 1 Tab/Cap

Montelukast Sodium 10mg
Lark Laboratories 1.08 Per 10 Tabs FIRST MONTETAR-10
(India) Ltd. l Tab/Cap SAME AS IN ITEM
Rupees One AND Pai* Ze,o Eight Only
zydus Healthcar€ 1.98 Per lOTabs SECOND ODIMONT lO

R One AND Paise Nine t

2015 Beclomethasone Dipropionate IP 200mcg (HFA Equal to or more than 120 MDI
Technology) Inhaler-
Each l\4etered Dose to contain:
Beclomethasone Dipropionate IP 200mcg
(HFA Technology)
Cipla Limited 0.30 Per 2OO MDI FIRST BECLATE 2OO CFC FREE INH
dose SAME AS IN TTEM
Rupees Nil AND Paise Three Zem Only

Midas Care 0.34 Per 24O MDI SECOND BESOT{E 2OO
Pl^. Ltd.
Rupees Nil AND Paise Thrce Four Only-
Page 25 of 50
l^a
Rate schedule of Running Rate contract No. u-25/12l142c-t46cl2oL9-Med v FoR Rc 143c
Valid from Thursday, October 1#h 2021 to Tuesday, October 31't 2023
Firm Name Firm Rate/ Prefercnce Description of s'tores ac@ptcd

unit Packing
2019 Indapamide (As SR)1.5m9 , Amlodipine Besilate 1 Tab/Cap

Equivalent to Amlodipine 2.5m9, Excepients QS Film
Coated Bi-Layered Tab/Cap-
Each Film Coated Bi-Layered Tab/Cap Contains:
Indapamide (As SR)1.5m9 ,
Amlodipine Besilate Equvalent To Amlodipine
2.5m9, Excepients QS
Serdia 7.41Per 10 Tabs FIRST NATRILAM 2.5
(India) Private
Limited
Rupees Seven AND Paise Four One Only
2022 Acenocoumarol / Nicoumalone Tab/Cap- l Tab/Cap

Acenocoumarol / Nicoumalone 2mg
Macleods L.77 Pet lOTabs FIRST ACENOMAC 2
Limited
Ruwes One AND Pai* Seven Seven Only
Zuventus 2.4OPer l0Tabs SECOND ARTIFLO2

Healthcare Limited l TAb/Cap SAME AS IN ITEM
Rupees Two AND Paise Fourzeru Only
2060 Ambroxol + Terbutaline Tab/Cap- 1 Tab/Cap

Each Uncoated Tab/Cap to contain: Ambroxol
Hrdrochloride 30 mg, Terbutaline Sulphate
Equivalent to Terbutaline 2.5 mg
Tablets (India) 2.31 Per 10 Tabs FIRST AMBROLITE ST
Rupees Two AND Paise Thrce One Only
/"-*
Page 25 of 50
Rate Schedule of Running Rate Contract No. U-25 | l2l t420-t46gl 20t9-Med V FOR RC 143C
Valid from Thursday, October l4th 2O2l to Tuesday, October 31st 2023
Item No Drug Description Packing

unit Packing
2061 Ambroxol + Terbutaline Syp- 100m1 Bottt

Each 5 ml to contain: Ambroxol Hrdrochloride IP 30
m9, Terbutaline Sulphate IP
Equivalent to
Terbutaline 2.50 mg, Guaiphenesin IP 50 mg,
Menthol IP 0.5 mq
Tablets (tndia) 29.12 Per 100m1 FIRST AMBROLITE 25 1OOML
Limited 100m1 Bottt Boftle SAME AS IN ITEM
Rupees Twenty Nine AND Paise One Two Only
2063 Inhaler- Equal to or more than 120 MDI

Each Inhaler to contain:
Fluticasone Propionate 250mca,
Formoterol Fumarate 6mcq
Midas Care 0,73 Per 240 MDI FIRST FTUTFOR 250 INHATATION
Pvt. Ltd.
Rupees Nil AND Paise Seven Thrce Only
Cipla Limited 0,89 Per 120 MDI SECOND MAXIFLO 250 INH
SAME AS IN ITEM
Rupees Nil AND Paise Eight Nine Only
2067 SC)Metoprolol Tab/Cap- 1 Tab/Cap

Each Prolonged Release Film Coated Tab/Cap to
contain : S(-)Metoprolol Succinate 47.50 mg Eqv. to
SC) Metoprolol Tartrate 50 mg
Zuventus 6.80 Per 10Tabs FIRST KIMETXL - 50
Healthcare Limited l Tab/Cap SAME AS IN ITEM
Rupees Six AND Paise Eight Zerc Only
Page 27 ol 5O
L/
*T
Employees' State Insurance Corporation
Rate Schedule of Running Rate Contract No. U-25lL2l L42C-t46ClzOLg-Med V FOR RC 143C
Valid from Thursday, October L4th 2O2L to Tuesday, October 31't 2023
Firm Name Firm Rate/ Firm Prefercnce Dexription of stores accepfud

unit Packing
2068 S(-)Metoprolol Tab/Cap- 1 Tab/Cap

Each CVPR/DR/SR/MR Tab/Cap to contain :
S(-)Metoprolol Succinate 23.75 mg Eqv. to S(-)
Metoprolol Tartrate 25 mg
Zuventus 5.80 Per 10 TabsFIRST KIMET XL 25 -
Healthcare Limited l Tab/Cap SAME AS IN ITEM
Rupees Five AND Paise Eight Zero Only
2069 licagrelor Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain:Tlcagrelor 90mg
Bajaj Healthcare L3.77 Per 14 Tabs FIRST SAME AS IN ITEM

Limited l Tab/Cap
Ruryes Thirteen AND Paise Seven Seven Only
2070 Ivabradine Tab/Cap- 1 Tab/Cap

Each Film Coated Tab/Cap to contain: I
vabradine Hcl Equivalent To IvabradineT,5mg
Serdia 17.86 Per 14Tabs FIRST CORALAN 7.sMG
Pharmaceuticals l Tab/Cap Manufactured byi-
(India) Private Les Laboratoires Seruier
Limited Industrie, France
SAME AS IN ITEM
Rupees Seventeen AND Paise Eight Six Only
2074 Indapamide + Amlodipine Tab/Cap- l Tab/Cap

Each Film Coated Bilayered Tab/Cap to
contain
Indapamide (As Sustained Release) 1.5m9 and
Amlodipine Besilate Equivalent to Amlodipine 10mg
Serdia 6.71 Per 10 Tabs FIRST NATRILAM 10
(India) Private
Limited
Rupees Six AllD Paise Seven One Only
Page 28 of 50
a
f^^r
Employees' Sbte fnsurance Corporauon
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OL9-Med V FOR RC 143C
Valid from Thursdan October 14th 2021 to Tuesday, October 31* 2023
ftem No Drug Desciption Packing

unit Packing
2076 f4icronised - Purified Flavonoid Tab/Cap- 1 Tab/Cap

Each Film Coated Tab/Cap to contain: Micronised -
Purified Flavonoid Fraction 1000m9-Composed Of
Diosmin 900m9 (90olo) And Flavonoids Expressed As
Hesperidin 100mc ( 100/o)
Serdia 14.29 Per 10 Tabs FIRST DAFLON 1OOOMG
(India) Private
Limited
Rupees Fourteen AND Paise TWo Nine Only
2077 Hemostat- 1 PFS

Each PFS to contain:
Hemostatic Matrix With Thrombin In Prifilled
Syringe 10ml
Baxter (India) Art 23094.00 Per 10ml PFS FIRST FLOSEAL 1OML
Ltd 1 PFS Manufactured Byr-
Baxter Healthcare
Corporation, 21026
Alexander court Hayward
California US 94545
SAME AS IN ITEM
Rupees Twenty Three Thousand Ninety Four Only
2078 Apixaban Tab/Cap- 1 Tab/Cap

Each Film Coated Tab/Cap to contain:
Apixaban 2.5m9
Pfizer Limited 50.54 Per 10 Tabs FIRST ELTQUTS 2.sMG
l Tab/Cap Manufactured By:-
M/s. Pfizer Manufacturing
Deutschland GmbH,
Betriebsstatte Freiburg
Mooswaldallee 1 NA Freiburg
(Germany) -79090
SAME AS IN ITEM
Rupees Fifty AND Paise Five Four Onlya
Page 29 of 50
Employees' SEte fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-t46Clz0tg-Med V FOR RC 143C
Valid from Thursday, October l4th 2O2L to Tuesday, October 31st 2023
Firm Name Firm Rate/ Firm Preference Dexription of storcs acepted

unit Packing
2079 Apixaban Tab/Cap- l Tab/Cap

Each Film Coated Tab/Cap to contain:
Apixaban 5mg
Pfizer Limited 52.95 Per 10 Tabs FIRST ErrQUrs 5MG
l Tab/Cap Manufactured By:-
Deutschland GmbH,
Betriebsstatte Freiburg
Mooswaldallee 1 NA Freiburg
(Germany) -79090
SAME AS rN rrEM,.
Rupees Fifry TWo AND Paise Nine Five Only
2080 Dabigatran Tab/Cap- l Tab/Cap

Dabigatran Etexilate 110 mg
Precise 10.50 Per 10 Caps FIRST SAME AS IN ITEM
Chemipharma Art l Tab/Cap
Ltd
Rupees Ten AM Paise Five Zero Only
Boehringer 50.00 Per 10 Caps SECOND PRADAXA 150 MG

Ingelheim India l Tab/Cap Manufactured by:-
Private Ltd Boehringer Ingelheim
Pharma GmbH & Co. KG,
Binger Str.173,55216,
Ingelheim am Rhein,
Germany
SAME AS rN rTEU
Rupees Fifty Only
{^^:
Page 30 of 50
Employees' State fnsuran@ Corpration
Rate schedule of Running Rate contract No. u-2slL2lL42c-t46clzot9-Med v FoR Rc 143c
Valid from Thursdan October 14b 2O2l to Tuesday, October 31't 2023
ftum No Description ll4ckin9
Firm Name Firm Rate/ Prefercnce De%ription of stores acepted
unit Packing
2081 Anticoagulants- 4ml

Each Kit to contain:
Two Componant Fibrin Sealant With Synthetic
Aprotinin (4ml)
Baxter (India) Pvt 13545.0O Per 4ml Kit FIRST TI$SEL LYO
Ltd 4ml Fibrjn Sealant VH ID powder and solvent
contains
Component -1 contain sealer protein solutjon
a. 1 vial of human fibrinogen
b. 1 vial of synthetic aprotinin solution
C.omponent -2 hrombin solution contain
a. 1 vlal thrombin 500 IU (Lyophilized)
b. 1 vial of calcium chloride
Manufactured By:-
Baxter AG, A-L22\ Vienna,
Industriestrasse 67 Vienna -
1221 Vienna (Austria)
SAME AS IN ITEM
Rupees Thirteen Tltousand Five Hundrd Forty Fiye Only,

2703 Terbutaline + Guiaphenesin + Ambroxol Syp- 100 ml Bottle
Each 5 ml to contain:
Terbutaline I.P 1.25m9 + Guiaphenesin I.P 50mg +
Ambroxol I.P 15mg Syrup Base QS
Wallace 20.60 Per 100m1 FIRST WALTUZ-BR

Pharmaceuticals 100 ml Bott Bottle SAME AS IN ITEM
Pvt. Ltd.
Rupees Twenty AND Paise Six Zeru Only
Page 31 of 50
Employees' State Insura nce Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|2OLg-Med V FOR RC 143C
Firm Name Firm Rate/ Preference De*ription of storcs ac@pted

unit Packing
2204 Dextromethorphan + CPM Syp- 100m1 Bottle

Each 5 ml to contain: Dextromethorphan I.P 10mg
+ Chlorpheniramine lulaleate I.P 2mg Syrup Base QS
Zenith Drugs hrt, 18.43 Per lOOml FIRST SAME AS IN ITEM
Ltd. 100m1 Bott Bottle
Rupees Eighteen AND Paise Four Three Only
Wallace 19.70Per 100m1 SECOND WALTUZ-DX

Pharmaceuticals 100m1 Bott Bottle SAME AS IN ITEM
Pvt. Ltd.
Rupees Nineteen AND Paise Seven ze,o Only

Gopaldas Visram 42.50 Per IOOmI THIRD SAME AS IN ITEM
And Company 100m1 Bott Bottle
Limited
Rupees Forly Two AND Paise Five Zero Only
2205 Ibutilide- 10ml

Each ml to contain:
Ibutilide Fumarate 0.1m9 ( Equivalent To Ibutilide
Freebase 0.087mg), Water For Injection
Zuventus 948.00 Per 10ml Vial
FIRST FTBRICOR
Healthcare Limited 10ml SAME AS IN ITEM
Rupees Nine Hundrcd FoW Eight Only
2207 Glyceryl Trinitrate Spray- 2OO MD

Glyceryl Trinitrate Spray -0.4 Mg
Medley 230.00 Per 200 FIRST GTN SPRAY
Pharmaceuticals 2OO MD Metered SAME AS IN ITEM
Ltd Dose
Rupees Two Hundrcd Thirty Only
Page 32 of 50 f<
Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|zOL9-Med V FOR RC 143C
ftem No Drug Description Packinq
Firm Name Firm Rate/ Preference De*ription of stotes accepEd

unit Packing
2208 Human Albumin- 100m1 Bottle

Each Bott to contain- Human Albumin 25olo 100 ml
In Flexible, Self Collapsible- Closed System Bags
Baxalta Bioscience 4233.00 Per 100m1 FIRST FLEXBUMIN
India Private 100m1 Bott Bag Manufactured by:-
Limited Baxalta US INC. USA
SAME AS IN ITEM
Rupees Four Thousand Two Hundred Thifi Thrce Only.
2209 Emicizumab Inj- 1 Vial

Each Vial Contains :
Emicizumab 30mg For Sub Cut Injection (R-DNA
Oricin)
Roche Products 40754,00 Per l
Vial FIRST HEMLIBRA 30 MG
(India) Pvt Ltd 1 Vial Manufactured by:-
M/s. F. Hoffmann-La Roche
Ltd, Wurmisareg,
CH- 4303/ Kaiseraugst,
Switzerland
SAME AS Iil ITEM
Rupees Forty Thousand Seven Hundrcd Fifry Four Only
22t0 Emicizumab Inj- 1 Vial

Each Vial Contains :
Emicizumab 60mg For Sub Cut Injection (R-DNA

Oriqin)
Roche Products 81437.00 Per Vial l FIRST HEMUBRA 60 MG
(India) Pr^ Ltd 1 Vial Manufactured by:-
M/s. F. Hoffmann-La Roche
Ltd, Wurmisweg,
CH- 4303, Kaiseraugst,
Switzerland
SAME AS IN TTEM
Rupees Eighty One Thousnd Four Hundrcd Thirty Seven Onllo
Page 33 of 50
Employees' Sbte fnsu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25lL2lL42C-l46Cl20!g-Med V FOR RC 143C
Valid from Thursday, October 14th 2O2L to Tuesday, October 31st 2023
Firm Name Firm Rate/ Prefercnce De ription of stotes accepfud

unit Packinc
22t1 Micronized - Purified Flavonoid Tab/Cap- 1 Tab/Cap

Each Film Coated Tab/Cap to contain :
- Purified Flavonoid Fraction 500m9
Micronized
Composed Of Diosmin 450m9 (90o/o) And
Flavonoids Expressed As Hesperidine 50mq (10olo)
Serdia 8.88 Per 10 Tabs FIRST DAFLON SOOMG
Pharmaceutacals l Tab/Cap SAME AS IN ITEM
(tndia) Private
Limited
Rupees Eight AND Paise Eight Eight Only
2299 Telmisaftan Tab/Cap: 1 Tab/Cap

Each Tab/Cap to contain: Telmisartan 20mg
USV Private Limited 0.73 Per 10 Tabs FIRST TAZLOC 2OMG

Rupees Nil AND Paise Seven Thrce Only

Macleods 1.14Per 10 Tabs SECOND MACSART 20
Limited
One AND Paise One Four
2302 Dabigatran Etexilate Tab/Cap- 1 Tablcap
Dabigatran Etexilate 150m9
Precise 12.50 Per 10 Caps FIRST SAME AS IN ITEM
Chemipharma hrt l Tab/Cap
Ltd
Rupees Tfuelve AND Paise Five Zem Only
Boehringer 50.00 Per 10 Caps SECOND PRADAXA 110 MG

Ingelheim India l Tab/Cap Manufactured by:-
Private Ltd Boehringer Ingelheim
Pharma GmbH & Co. KG,
Binger Str.173,552L6,
Ingelheim am Rhein,
Germany
SAME AS IN ITEM
Ruryes Fifty Only ?
4
Page 34 of 50
f'y
Employees' Sbte fnsura nce Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-t46Cl2OL9-Med V FOR RC 143C
Valid from ThuEday, October L4rh 2O2L to Tuesday, October 31st 2023
Firm Name Fim Rate/ Firm Prefercnce Description of stores ac@phd

unit Packing
2303 Acetyl Salicylic Acid + Atorvastatin Tab/Cap- 1 Tab/Cap

Acetyl Salicylic Acid 75m9, Atorvastatin 20mg
Cipla Limited 1.69 Per 10 Caps FIRST ATORLIP ASP 20 CAP
I Tab/Cap (GESTRO - RESISTANT TABLEI)
SAME AS IN ITEM
Rupees One AND Paise gix Nine Only
2306 Diltiazem CR/ SR/ DR/ MR Tab/Cap- 1 Tab/Cap

Each CR/ SR/ DR/ MR Tab/Cap to contain:
Diltiazem 90mg
Modi Mundipharma 1.71 Per 10 Tabs FIRST DILCONTIN XL 90
Private Limited l Tab/Cap SAME AS IN ITEM
Rupees One AND Pai*5even One Only
2309 Codein Lint, Syp/Susp- 100m1 Bottle

Chlorpheniramine Maleate 4mg,
Codeine Phosphate 10mq
Windlas Biotech 28.30 Per 100m1 FIRST WIROF SYRUP
Private Limited 100m1 Bott Bottle SAME AS IN ITEM
Rupees Twenty Eight AND Paise Th,ee Ze,o Only
Concept 29.60 Per 100ml THIRD CODICON COUGH SYP

Pharmaceuticals 100m1 Bott Bottle SAME AS IN ITEM
Ltd.
Rupees Twenty Nine AND Paise Six Zero OnlYo
Page 35 of 50
fry
Employees' State f nsu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|zOL9-Med V FOR RC 143C
Firm Name Firm Rate/ Preference Description of sfurcs ac@phd

unit Packing
2312 Gabapentin + Nortriptyline Tab/Cap- 1 TAB/CAP

Gabapentin 100m9, Notriptyline 10mg
Pulse 2.7L Per 10 Tabs FIRST DOLONEURON NT 1OO
Ltd
Rupees Two AND Paise Seven One Only
23t7 Pregabalin Tab/Cap- l Tab/Cap

Each PLAIN/SR/CR/DR/ER/MR Tab/Cap to contain:
Pregabalin 75mg
Cipla Limited 1.19 Per 10 Caps FIRST NOVA 75
Rupees One AND Paise One Nine Only
Mesmer 1.58 Per 10 Tabs SECOND GABAWIN 75

Rupees One AND Paise Five Eight Only
Zim Laboratories 1.73 Per 10 Caps THIRD EPINOZ-7s

Ruryes One AND Paise Seyen Three Only
1040b Beclomethasone Inhaler- Equal to or more than 120 MDI

Beclomethasone Dipropionate 100mcg.
Midas Care O.42 Per 240 MDI FIRST BESONE 1OO INHALATION
Pvt. Ltd.
Rupees Nil AND Paise Four Two Only
Page 36 of 50
ta
Rate Schedule of Running Rate contract No. U-25l12l142C-!46ClzOLg-Med v
FoR Rc 143C
Valid from Thursday, October 14th 2021 to Tuesdan October 31.t 2023
ftem No Druo Pa
Firm Name Firm Rate,/ Prefercnce De*ription of s,totes ac@P Ed

unit Packing
Salbutamol RotacaP- 1 Cap

1043a
Each Rotacap to contain : Salbutamol 200mca
0.40 Per 60 Caps FIRST ASTHALIN ROTACAPS

Cipla Limited
I Cap Bottle SAME AS IN ITEM
Ru, Nil AND Paise Four Zerc

1056a Metoprolol Tab/CaP- l Tab/Cap
Each Tab/CaP to contain :
Metoprolol Tartrate 50 mg
Psychotropics India 0.39 Per 14Tabs FIRST MT tOC 50

l Tab/Cap SAME AS IN TTEM
Limited
Rupees Nil AND Paise Three Nine Only
Intas 1.51 Per 10 Tabs SECOND EMBETA.sO

l Tab/Cap SAME AS IN TTEM
Pharmaccuticals
Ltd
Rupees One AND Paise Five One OnlY
1060a Iso-sorbide Mononitrate Ta blCap- l Tab/Cap

Iso-sorbide-5-Mononitrate 20 mg
wallace 0.26 Per 10 TAbS FIRST MONICOR

Pharmaceuticals
Pvt. Ltd.
Rupes Nil AIfiD Pai* ffuo Six OnlYa

dS 4F! ,.8 F[
,E* =+h rrr*, !c?
-:: tJi*. g"-dtJc5
/*:
Page 37 of 50
Employees' StaE fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-t46Cl2OLg-Med V FOR RC 143C

unit Packing
1067b Prazosin SR Tab/Cap- 1 Tab/Cap

Each SR Tab/Cap to contain: Prazosin Hcl 2.5 mg
Hindustan 3.51 Per 14 Tabs FIRST HIPRACIN

Laboratories l Tab/Cap Strip SAME AS IN ITEM
Limited
Rupees Three AND Pai* Five One Only
Intas 5.33 Per 30 Tabs SECOT{D PRAZOPILT XL 2.5

Ltd
Rupees Five AND Paise Thrce Thte Only
Pfizer Limited 6.60 Per 30 Tabs THIRD MINIPRESS XL 2.5MG

l Tab/Cap Manufactured by:-
M/s, Pfizer Pharmaceuticals
[LC,P.O Box No. 628,K 58.2
RD 2,Barceloneta P R
00617,USA
SAME AS IN ITEM
Rupees Six AND Paise Six Zero Only
7067c Prazosin SR Tab/Cap- l Tab/Cap
Each SR Tab/Cap to contain: Prazosin Hcl 5m s
Hindustan 4.85 Per 14Tabs FIRST HIPRACIN-S
Laboratories l Tab/Cap SAME AS IN ITEM
Limited
Rupees Four AND Palx Eight Five Only
Intas 6,17 Per 30 Tabs SECOND PRA:ZOPLL XL 5
Ltd
Rupees Six AND Pal* One Seven Only
Pfizer Limited 7.22Per 30 Tabs THIRD MINIPRESS XL sMG

l Tab/Cap Manufactured by:-
M/s, Pfizer Pharmaceuticals
LLC,P.O Box No. 628,K 58.2
RD 2,Barceloneta P R
00617,USA
SAME AS IN ITEM
RupeesSeven AND Paise Two Two Onty ?
Page 38 of 50 4-.,r'"*
Employ@s' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2Ol9-Med V FOR RC 143C
Valid from Thurcday, October 14lj'2O2L to Tuesday, October 31't 2023
ftem lUo Drug Packing
Firm Name Firm RaE/ Firm Preference Dexription of sbrcs acePhd

unit Packing
1068b Ramipril Tab/ Cap- l Tab/Cap

Each Tab/ Cap to contain: Ramipril 2.5m9
Cipla Limited 0.48 Per 10 TAbS FIRST RAMIPRES 2.5

Rupees Nil AND Paise Four Eight Only
Sanofi India 3.00 Per 1 E 2.5MG

Limited l Tab/Cap IN ITE Mn
Rupees Three OnlY
1068c Ramipril Tal l Tab/Cap

Each Ta blCi
Cipla Limited 0.50 Per 10 TabS FIRST RAMIPRES 5

Rupees Nil AND Paise Five Zeto OnlY
Macleods 0. 10 Tabs SECOND MACPRIL 5

Pharmaceuticals 1 SAME AS IN TTEM
Limited
Rupees
Sanofi India 5.52 Per 15 tabs CARDACE sMG

Rupees Five AND Paise Six Two Onll,

/
od^-a-.r>-At
i-
Page 39 of 50
Rate Schedule of Running Rate Contract No. U-25l12l142C-l46Cl2OL9-Med V FOR RC 143C

unit Packing
1115b Phenobarbitone TabiCap- l Tab/Cap

Each Tab/Cap to contain: Phenobarbitone-30m9
Intas 0.49 Per 10 Tabs FIRST PHENOBARB 30

Ltd
Rupees Nil AND Paise Four Nine Only
Ll27a Carbamazepin CR Tab/Cap- 1 Tab/Cap

Each CR Tab/Cap to contain: Carbamazepin 200m9
Sun Pharma 1.11 Per 10 Tabs FIRST SAME AS IN ITEM

Laboratories l Tab/Cap
Limited
Rupees One AND Paise One One Only
1370b Torsemide TabiCap- 1 Tab/Cap

Each Tab/Cap to contain: Torsemide 20mg
Cipla Limited 0,55 Per 15 Tabs FIRST DYTOR 20

Rupees Nil AND Paise Six Five Only

Centaur 2.29Per l0Tabs SECOND MELTOR 20MG
Pharmaceuticals l Tab/Cap SAME AS IN TTEM
Prrt. Ltd.
Rupees Two AND Paise Two Nine Only
Intas 3.63Per 15 Tabs THIRD TOR-2O

Ltd
Rupees Thrce AND Paise Six Three Only,

t-
PaBe 40 of 50
Rate Schedule of Running Rate Contract No. U-25/121142C-t46Cl20t9-Med V FOR RC 143C
Firm Name Firm Rate/ Prefercnce Description of storcs ac@pbd

unit Packing
1430b Mirtazapine Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Mitazapine 15mg
Psychotropics India 1.12 Per 10 Tabs FIRST MITRAPIT 15

Limited l Tab/Cap SAME AS II{ ITEM
Rupees One AND Paie One fwo Only

Sun Pharma 6,67 Per 10 Tabs SECOND SAME AS IN ITEM
Laboratories l Tab/Cap
Limited
RuBes Six AND Paise Six Seven Only
324a Clobazam Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Clobazam 5 mg
Intas 2.27 Per 15 Tabs FIRST CTOBA-s TAB

Ltd
Rupees TWo AND Paise Two Sevan Only
324b Clobazam Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Clobazam I.P.10 mg
Intas 4,04 Per 15 Tabs FIRST CTOBA-lo TAB

z
Ltd
Rupees Four AND Pai*Zerc Four Onllo
Page 41 of 50
Rate Schedule of Running Rate Contract No.U-25lLzll42C-L46Cl2OL9-Med V FOR RC 143C
Firm Name Firm Rate/ Prefercnce Dexription of storcs acephd

unit Packing
32b Salbutamol Resp. Soln- 15 ml Bottle

Each ml to contain:
Salbutamol Sulphate Eqv. to Salbutamol 5 mg in
Normal Saline Soln.
Cipla Limited 8.4O Per 15ml FIRST ASTHALIN RESPIRATOR SOL.
15 ml Bott Bottle SAME AS IN ITEM
Rupees Eight AND Paise Four Ze,o Only
336b Carvedilol Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Carvedilol 6.25m9
Themis Medicare 0.214 Per 10 Tabs FIRST cvl 6.25

Rupees Nil AND Paise Four Four Only
366a Enoxaprin Inj- 1 PFS

Enoxaprin Sodium 20 mg / 0.2 ml.
Bharat Serums And 140,00 Per 1 PFS FIRST LONOPIN 2OMG
Vaccines Limited 1 PFS SAME AS IN ITEM
Rupees One Hund,ed Forty Only
Sanofi India Per

280.95 1 PFS SECOND CLEHNE 20MG
Limited l PFS Manufactured by:-
M/s. Sanofi Winthrop
Industrie, France
SAME AS IN ITEM
Rupees Two Hundred Eighty AND Paise Nine Five Only
{^ry
Page 42 of 50
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|zOLg-Med v FOR RC l43C
Firm Name Firm Rate/ Prefetence Description of storcs accephd

unit Packing
366c Enoxaparin 60 mg/0.6m1 Inj- 1 PFS

Each PFS to contain: Enoxaparin 60 mg/0.6m1
Virchow Biotech 184.30 Per 1 PFS FIRST VOXAPARIN 60

A^. Ltd I PFS SAME AS IN ITEM
Rurees One Hundtd Eighty Four AND Pai* Thrce Zero Only
Emcure 200.00 Per l PFS SECOND TOMOH 60 MG

Pharmaceuticals 1 PFS SAME AS IN ITEM
rtd
Rupees Two Hundrcd Only
Bharat Serums And 215.00 Per 1 PFS THIRD TONOPIN 6OMG

Vaccines Limited 1 PFS SAME AS IN ITEM
Rupees TWo Hundrcd Fifteen Only
420a Fluticasone + Salmeterol Inhaler- Equal to or more than 120 MDI

Each Metered Dose to contain: Salmeterol 25mcg,
Fluticasone 50mcg
Midas Care 0,65 Per 240 MDI FIRST FLUSAL 50 INHALATION
Pr^. Ltd.
R Nil AND Paise Six Five On

423a Nicorandil Tab/Cap- l Tab/Cap
Each Tab/Cap to contain: Nicorandil 5mg
Macleods 1.60 Per 20 Tabs FIRST K-COR 5

Pharmaceuticals l Tab/Cap Bottle SAME AS IN ITEM
Limited
Rupees One AND Paise Six Zeru Onlyz
Page 43 of 50
Employees' State f nsu ra nce Corpration
Rate Schedule of Running Rate Contract No, U-25ll2ll42C-t46cl2OLg-Med V FOR RC 143C
Valid from Thursday, October L4th 2O2, to Tuesday, October 31st 2023
Firm Name Firm Rate/ Prefetence Dexription of storcs acephd

unit Packing
433b Sodium Valproate + Valproic Acid CR Tab/Cap- 1 Tab/Cap

Each CR Tab/Cap to contain:
(Sodium Valproate + Valproic Acid) Eqv. to Sodium
Valproate 500mq.
Pulse 1.78 Per 1O Tabs FIRST NEW VAT CR 5OO
Ltd
Rupees One AND Paise Seven Eight Only
Psychotropics India 1.79 Per 10 Tabs SECOND TAB VALATE CHRONO 500
Rupees One AND Paise Seven Nine Only
Sanofi - Synthelabo 7,78PEr 10 Tabs THIRD VALPARIN CHRONO 5OO

(India) Private l Tab/Cap SAME AS IN ITEM
Limited
Rupes Seven AND Paise Seven Eight Only
44b Propranolol Tab/Cap- l lab/Cap

Each Tab/Cap. to contain: Propranolol 40mg
Intas 1.32 Per 10 Tabs FIRST PROVANOL-40

Ltd
R One AND Paise Thrce TWo

470a Perindopril Tab/Cap- 1 Tab/Cap
Each Tab/Cap to contain: Perindopril 2mg
Serdia 6.00 Per 10 Tabs FIRST COVERSYT 2MG

(India) Private
Limited
Rupees Six Onl2
Page 44 of 50
Employees' Sbte fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OLg-Med V FOR RC 143C
Valid from Thursday, October L4rh 2O2l to Tuesday, October 31* 2023
Firm Name Firm Rate/ Preference Description of stores acepfud

unit Packing
470c Perindopril Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Perindopril Erbumine Bmg
Zim Laboratories 10.06 Per 10 Tabs FIRST ZIMPRII.S

Limited l Tab/Cap
Rupees Ten AND Paise Zerc Six Only

Serdia 12.14 Per 10 Tabs SECOND COVERSYL 8MG
(India) Private
Limited
Rupees fwelve AND Paise One Four Only
473a Resperidone Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Resperidone 1mg
Mesmer 1.51 Per 10 Ta bs FIRST RI

Rupees One AND Paise Five One Only
474b Olanzapine Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Olanzapine 5mg
Hab 0.29 Per 10 Tabs FIRST OLANZAP.S

Research Ltd
Rupees Nil AND Paise Two Nine Only

Mesmer O.43 Per 10 Tabs SECOND OLZIC 5 MG
Rupees Nil AND Paise Four Thrce Only
Page 45 of 50
P
Employes' State fnsuran@ Corporation
Rate Schedule of Running Rate Contract No.U-25lt2ll42o-l46cl2OL9-Med V FOR RC 143C
Valid from Thursday, October L4n' 2O2l to Tuesday, October 31st 2023
ftum No Drug Description Packing
Firm Name Firm Rate/ Firm Ptefercnce De*ription of s'torcs ac@phd

unit Packing
475b Haloperidol Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Haloperidol 5mg
Micron t.44 Per 10 Tabs FIRST SAME AS IN ITEM

Rupes One AND Pai* Four Four only
477a Amitripryline Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Amitriptyline 10mg
Mesmer 0.52 Per 10 Tabs FIRST AMICON 10 MG

Rupes llil AND Paise Five Two Onll
477b Amitriptyline Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Amitriptyline 25mg
Mesmer 0.61 Per 10 Tabs FIRST AMICON 25 MG

Rupees Nil AND Pai* Six One OnlY
486a Paroxetine Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Paroxetlne 10mg
Zydus Healthcare 0.83 Per loTabs FIRST XET 10

Rupees Nil AND Paise Eight Thtee Only
Intas 7.85 Per 10 Tabs SECOND PEXEP-IO

ttd
Rupees Seven AND Paise Eight Five Onlyn
l"-Y
Page 46 of 50
Employees' State fnsurance Corpration
Rate Schedule of Running Rate Contract No. U-25/121142C-l46Clz0l9-Med V FOR RC 143C
Firm Name Firm Rate/ Prefetence Dexription of storcs acepted

unit Packinq
486b Paroxetine Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Paroxetine 20mg
Zydus Healthcare 1.39 Per 10 Tabs FIRST XET 20

Rupees One AND Paie Th,ee Nine Only
Intas Per 10 Tabs

11.05 SECOND PEXEP-2O
Pharmaceuticals l Tab/Cap SAIIE AS IN ITEM
Ltd
Eleven AND Paise Zero Five

525a Metoprolol ER Tab/Cap- l Tab/Cap
Each ER Tab/Cap to contain:
f4etoprolol Succinate 47.5m9 Equivalent to
Metoprolol Tartrate 50mq.
Pulse 0.57 Per loTabs FIRST METTOC ER 50
Pharmaceutical Pvt l Tab/Cap SAME AS IN TTEM
Ltd
Ruryes Nil AND Paise FiYe Seven Only
Cipla Limited 0.65 Per 15 Caps. SECOND METOTARXR 50

l Tab/Cap (HARD GELANN EXTENDED.
RELEASE CAPSULE)
SAME AS IN ITEM
Rupees Nil AND Paise Six Five Only

Macleods 3,40 Per 10 Tabs THIRD METOMAC 50
Pharmaceuticals l Tab/Cap SAME AS IN rTEMz
Limated
Rupees fhree AND Paise Four Zeto Only
*
Page 47 of 50
Employes' State fnsu ra nce Corporation
Rate schedule of Running Rate contract No. u-25l12l142c-t46cl2ol9-Med v FoR Rc 143c
ftem No Drug Packing
Firm Name Firm RaE/ Firm Prefercnce De*ription of stores ac@pted

unit Packins
527a Gabapentin Tab/Cap- 1 Tab/Cap

Each Tab/Cap to contain: Gabapentin 300mg
Signature 1.19 Per 10 Caps FIRST SAME AS IN ITEM
Phytochemical l Tab/Cap
Industries
Rupees One AND Paise One Nine Only
Zim Laboratories 1.74 Per 1O Caps SECOND GABAZIM 3OO
Rupees One AND Pai* Seven Four Only
Mesmer 2.23Per 10Tabs THIRD PROGABA3OO MG

Two AND Paise Two Three

555a Clozapine Tab/Cap- 1 Tab/Cap
Each Tab Ca to contain: Clozapine 25mq
Mesmer 0.88 Per l0 Tabs FIRST ZAPORIL 25 MG
Rupees Nil AND Paise Eight Eight Only

555b Clozapine Tab/Cap- l Tab/Cap
Each Tqb/Cap to contain: Cloza pine 100m9
Psychotropics India 1.67 Per 10 Tabs FIRST PIIZEP 1OO
Limited l Tab/Cap SAME AS IN TTEM
Rupees One AND Paie Slx Seven Only

Mesmer 1.87 Per 10 Tabs SECOND ZAPORIL lOO MG
Pharmaceuticals l Tab/cap SAME As IN ITEM
Rupees One AND Pai* Eight*ven Only

a
'Jd.-'-
t-.
Page 48 of 50
Employees' State Insuran@ C.orporation
Rate Schedule of Running Rate Contract No. U-25/121142C-l46ClzOLg-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31d 2023
Firm Name Firm Rate/ Prefercnce Dexription of stores ac@pted

unit Packing
556a Escitalopram Tab/Cap- I Tab/Cap

Each Tab/Cap to contain: Escitalopram 10 mg
Hab 0.42 Per 10 Tabs FIRST ES-TDO(A
Research Ltd
Rupees Nil AND Paise Four Two Only

Pulse 0.64Per 10 Tabs SECOND LEXADEP 10
Ltd
Rupees Nil AND Pai* Six Four Only
Mesmer 0.79 Per 10Tabs THIRD ESCIPRA 10 MG
Pharmaceuticals l Tab/CaP SAME AS IN ITEM
Ruryes Nil AllD Paise Seven Nine Only
556b Escitalopram Tab/Cap- l Tab/Cap

Each Tab/Cap to contain: Escitalopram 20 mg
Mesmer L.24Per 10 Tabs FIRST ESCIPRA 20 MG

Rupees One AND Pai* Two Four Only
557a Dalteparin Sodium Inj- 1 PFS

Dalteparin Sodium 2500 IU Units
Pfizer Prcduct 157.98 Per 1 PFS FIRST FRAGMIN 25OO IU
India Private Ltd 1 PFS Manufactured By:-
Belgium NV Rijksweg 12
Puurs NA(Belgium), B-2870
Belgium
SAME AS IN ITEM..4?
Rupees One Hund,ed Fifty Seven AND Paise Nine Eight Only
Page 49 of 50
ft
Employes' SbE fnsurance CorPoration
V FOR RC 143C
Rate Schedule of Running Rate contract No. U-25/121142C't46Cl2OLg-Med
Valid from Thurcday, October 14th 2021 to Tuesday, October 31"t 2023
ftem No
Firm Name Firm Rate/ Preference Description of stores accePbd

unit Pa*inq
Dalteparin Sodium Inj- 1 PFS

557b
Dalteparin Sodium 5000 IU Unlts
Pfizer Product 260.23 Per 1 PFS FIRST FRAGMIN SOOO IU
India Private Ltd 1 PFS Manufactured BY:-
M/s. Pfi zer Manufacturing
--- Belgium NV Riiksweg 12
Puurs NA(Belgium), B-2870
Belgium
SAME AS rN rrEM7.
Rupees Two Hundrcd Sixty AND Paise TWo Thte Only
68a Ethamsylate Tab/CaP- l Tab/Cap

Each Tab/Cap to contain Ethamsylate 250 mg
Windlas Biotech 0.70 Per IOTAbS FIRST FIXOHEAM.25O

I Tab/Cap SAME AS IN ITEM
Private Limited
Rupees Nil AND Paise Seven Zero Only
Juggat Pharma 4.65 Per 10 Tabs SECOND BOTROSTATTABLETS

(Pharma Division l Tab/Cap SAME AS IN ITEM a.
Of Jagdale
Industries Private
Limited)
Rupees Four AND Paise Six Five OnlY
Streptokinase Inj- 1 Vial

74a
Each Vial to contain: Streptokinase I.P 7.5 Lac IU
Bharat Serums And 883.00 Per l Vial FIRST THROMBOFLUX 75OOOO I.U
Vaccines Limited l Vial SA]{E-.AS..II.{ ITEM
,
Rupees Eight Hundrcd Eighty Three Only.
Page 50 of 50
lT

Gentral Rate Contract: Supply of

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Gentral Rate Contract: Supply of

Uploaded by

Copyright:

Available Formats

ESIC

GENTRAL RATE CONTRACT NO. - 143(C)

DRUGS FOR RESPIRATORY SYSTEM

STR]CTLY FOR OFFICIAL USE

EMPLOYEES' STATE INSURANCE CORPORATION

STRICTLY FOR OFFICIAL USE

1. Fonararding letter along with terms & t-x

2. List of Approved Pharmaceutical firms. 1-3

?,FtA R*- - a4/rrl

Sub r PURCHASE OF UNDER THE E.S.I.

Please flnd for

Validity of this i.e. w.e.f,

Further, the following terms operation of the Rate

1. ImmediatelY on receipt of this communication, the Chief Direct Demanding Officers

5. The Chief DDOs shall monitor of the Ra holding flrms in regard

7. It will be ensured beford'placing ordqr. by the t necessary

No guarantee can be given..as io the.,minimim quantiry frntir iritt be.di'awn against

13. During transit pharmaceutical firm should maintain the recommended

Each packing shall be printed with nomenclature of the shall be

b) Loose supplies/damaged packing/tempered or damaged labeled supplies shall not be

c) Supplies to be made in, propeir boxes' . -i. - l

g) All primary packing containers should be strictly conforming to the specifications

h) Packing should be able to prevent damage or deterioration during transit.

pilfer-proof sealito ensurergenuinenels of the products packed and the corredness of

18. Life Period :

c) Imported Drugs: As on the date of delivery, Drugs should have a minimum

b. The Director General, ESI Corporation shall be at liberty to undeftake regular

at the time of suoPlv

h If the product is found t6 be.'not'.of standdid. quality','the cost of testing will be

Ifstandard quality is not maintained in h'l'o batches in two years

bv ESIC for each categorv of defects, described as under:-

CATEGORY'A'DEFECT (Spurious / Adulterated Drugs)-

B, CATEGORY'B' DEFECT (Grossly Substandard Drugs)

I. If single item/ Batch of item is declared NSQ under Category C

b. If the pharmaceutical firm esupply order within the

That extension of deliverv oeriod cannot be claimd as a malter of

d If the iterns/ drugs are n ot suppli d (as i ndicated above

25. Quoting L'

b. GST, if extra, where legally leviable and intended to be claimed, should be

Any payments that have been demanded as per the provisions of

. The Corporation reserves its right to take appropriate legal action

This issue with the a

Dv. Medical Commissioner (RC)

SNo, Name of the Firm

1 Abbott India Limited

3 Baxalta Bioscience Ind ia Private Limited

6 Boeh In heim India Private Ltd

18 Lark Laboratories ndia Ltd.

SNo. Name of the Firm

23 Midas G re Pharmaceuticals ht. Ltd.

24 Modi Mund Prlvate Limited

25 Overseas Healthcare h/t Ltd

28 Precise Chemi AA Ltd

40 Themis Medicare Limited

43 Virchow Biotech h/t. Ltd

44 Wallace Pha rmaceutica ls h/t. Ltd.

45 Windlas Biotech Private Limited

SNo, Name of the Firm

47 Zim Laboratories Limited

48 Zuventus Healthcare Limited

rs*t Kffi r43{c}

Vendor Name Term 1 weeks (of the actual date